Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd.
1:17-cv-11008
Overview
Case Number
1:17-cv-11008
Filing Date
2017-05-31
Status
Terminated
Termination Date
2018-07-31
Court
District Court, D. Massachusetts (mad)
Presiding Judge
Nature of Suit
830 Patent
Jurisdiction Type
Federal Question
Cause of Action
35:271 Patent Infringement
Jury Demand
Both
Parties
Defendant
Celltrion Healthcare Co., Ltd. Operating Company
Represented By
0 Attorneys Listed
No attorneys available
Plaintiff
Court & Judges
Court
District Court, D. Massachusetts (mad)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Procedural Motions & Interlocutory Orders
Total Motions
390
Dispositive
209
Granted
0
Denied
6
Pending / Review
126
Motions by Category
Motion to Dismiss
127
Procedural / Extension Motion
108
Motion to Stay
4
Motion to Compel Discovery
65
Motion to Strike / Sanctions
4
Motion for Summary Judgment (Rule 56)
45
Motion for Summary Judgment (Infringement)
37
Key Dispositive Motions & Rulings
Motion for Summary Judgment (Rule 56)
Pending / Under Review
NOTICE OF APPEAL to the Federal Circuit as to 397 Judgment, 393 Order on Motion for Summary Judgment,(Filing fee: $ 505, receipt number 0101-7289422 Fee Status:...
Entry #399 • 2018-08-24
Document →
Motion for Summary Judgment (Rule 56)
Pending / Under Review
NOTICE OF APPEAL as to 397 Judgment, 393 Order on Motion for Summary Judgment, by Janssen Biotech, Inc. Filing fee: $ 505, receipt number 0101-7289422 Fee Statu...
Entry #398 • 2018-08-23
Document →
Motion for Summary Judgment (Infringement)
Pending
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is AL...
Entry #393 • 2018-07-30
Document →
Motion for Summary Judgment (Infringement)
Pending
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is AL...
Entry #393 • 2018-07-30
Document →
Motion for Summary Judgment (Infringement)
Pending / Under Review
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is AL...
Entry #393 • 2018-07-30
Document →
Motion for Summary Judgment (Rule 56)
Denied
Judge Mark L. Wolf: "[I]t is hereby ORDERED that: 1. If the pending motion for summary judgment on ensnarement is denied, a telephone conference will be held to...
Entry #381 • 2018-06-28
Document →
Docket Entries
(838 total)
Pleading / Complaint
COMPLAINT against Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd. Filing fee: $ 400, receipt number 0101-6651700 (Fee Status: Filing Fee paid), filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Category Form)(Casey, Alison) (Main Document 1 replaced to include correct Atty. signature on 6/1/2017) (Franklin, Yvonne). (Entered: 05/31/2017)
Entry #1 • 2017-05-31
1
Pleading / Complaint
COMPLAINT against Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd. Filing fee: $ 400, receipt number 0101-6651700 (Fee Status: Filing Fee paid), filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Category Form)(Casey, Alison) (Main Document 1 replaced to include correct Atty. signature on 6/1/2017) (Franklin, Yvonne). (Entered: 05/31/2017)
Entry #1 • 2017-05-31
2
Pleading / Complaint
COMPLAINT against Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd. Filing fee: $ 400, receipt number 0101-6651700 (Fee Status: Filing Fee paid), filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Category Form)(Casey, Alison) (Main Document 1 replaced to include correct Atty. signature on 6/1/2017) (Franklin, Yvonne). (Entered: 05/31/2017)
Entry #1 • 2017-05-31
2
Pleading / Complaint
COMPLAINT against Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd. Filing fee: $ 400, receipt number 0101-6651700 (Fee Status: Filing Fee paid), filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Category Form)(Casey, Alison) (Main Document 1 replaced to include correct Atty. signature on 6/1/2017) (Franklin, Yvonne). (Entered: 05/31/2017)
Entry #1 • 2017-05-31
2
REPORT ON THE FILING/TERMINATION OF AN ACTION REGARDING PATENT OR TRADEMARK. (Casey, Alison) (Entered: 05/31/2017)
Entry #2 • 2017-05-31
1
CORPORATE DISCLOSURE STATEMENT by Janssen Biotech, Inc. identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc... (Casey, Alison) (Entered: 05/31/2017)
Entry #3 • 2017-05-31
1
NOTICE of Appearance by Alison C. Casey on behalf of Janssen Biotech, Inc. (Casey, Alison) Modified on 6/1/2017 document removed. Filer refiled with correct Atty. name at D.E. #7 (Franklin, Yvonne). (Entered: 05/31/2017)
Entry #4 • 2017-05-31
1
Court Order
ELECTRONIC NOTICE of Case Assignment. Judge Mark L. Wolf assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Judith G. Dein. (Abaid, Kimberly) (Entered: 06/01/2017)
Entry #5 • 2017-06-01
1
Summons Issued as to Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (DaSilva, Carolina) (Entered: 06/01/2017)
Entry #6 • 2017-06-01
1
NOTICE of Appearance by Alison C. Casey on behalf of Janssen Biotech, Inc. (Casey, Alison) (Main Document 7 replaced and modified on 6/8/2017) to correct plaintiffs name (Franklin, Yvonne). (Entered: 06/01/2017)
Entry #7 • 2017-06-01
1
NOTICE of Appearance by Heather B. Repicky on behalf of Janssen Biotech, Inc. (Repicky, Heather) (Main Document 8 replaced and modified on 6/8/2017) to correct plaintiffs name (Franklin, Yvonne). (Entered: 06/01/2017)
Entry #8 • 2017-06-01
1
NOTICE of Appearance by Dennis J. Kelly on behalf of Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. (Kelly, Dennis) (Entered: 07/11/2017)
Entry #9 • 2017-07-11
1
NOTICE of Appearance by Andrea L. Martin on behalf of Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. (Martin, Andrea) (Entered: 07/11/2017)
Entry #10 • 2017-07-11
1
CORPORATE DISCLOSURE STATEMENT by Celltrion Healthcare Co., Ltd., Celltrion, Inc.. (Martin, Andrea) (Entered: 07/11/2017)
Entry #11 • 2017-07-11
1
CORPORATE DISCLOSURE STATEMENT by Hospira, Inc. identifying Corporate Parent Pfizer, Inc. for Hospira, Inc... (Martin, Andrea) (Entered: 07/11/2017)
Entry #12 • 2017-07-11
1
Motion to Dismiss
Pending / Under Review
MOTION to Dismiss for Lack of Jurisdiction Lack of Standing by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 07/11/2017)
Entry #13 • 2017-07-11
1
Motion to Dismiss
MEMORANDUM in Support re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A (Redacted))(Martin, Andrea) (Entered: 07/11/2017)
Entry #14 • 2017-07-11
1
Motion to Dismiss
Pending / Under Review
MEMORANDUM in Support re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A (Redacted))(Martin, Andrea) (Entered: 07/11/2017)
Entry #14 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
1
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
Pending / Under Review
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 1-16] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Exhibit 12, # 12 Exhibit 13, # 13 Exhibit 14, # 14 Exhibit 15, # 15 Exhibit 16)(Martin, Andrea) (Entered: 07/11/2017)
Entry #15 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
1
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
Pending / Under Review
ADDENDUM re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Exhibits 17-31] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20, # 4 Exhibit 21, # 5 Exhibit 22, # 6 Exhibit 23, # 7 Exhibit 24, # 8 Exhibit 25, # 9 Exhibit 26, # 10 Exhibit 27, # 11 Exhibit 28, # 12 Exhibit 29, # 13 Exhibit 30, # 14 Exhibit 31)(Martin, Andrea) (Entered: 07/11/2017)
Entry #16 • 2017-07-11
2
Motion to Dismiss
Pending / Under Review
Assented to MOTION to Seal re Motion to Dismiss by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 07/11/2017)
Entry #17 • 2017-07-11
1
SEALED UNREDACTED DOCUMENTS RE: 13 (Attachments: # 1 Appendix A, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 6, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 23, # 11 Exhibit 26, # 12 Exhibit 27, # 13 Exhibit 28)(14) Cover Letter) (Franklin, Yvonne). (Entered: 07/12/2017)
Entry #18 • 2017-07-12
1
SEALED UNREDACTED DOCUMENTS RE: 13 (Attachments: # 1 Appendix A, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 6, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 23, # 11 Exhibit 26, # 12 Exhibit 27, # 13 Exhibit 28)(14) Cover Letter) (Franklin, Yvonne). (Entered: 07/12/2017)
Entry #18 • 2017-07-12
2
SEALED UNREDACTED DOCUMENTS RE: 13 (Attachments: # 1 Appendix A, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 6, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 23, # 11 Exhibit 26, # 12 Exhibit 27, # 13 Exhibit 28)(14) Cover Letter) (Franklin, Yvonne). (Entered: 07/12/2017)
Entry #18 • 2017-07-12
2
SEALED UNREDACTED DOCUMENTS RE: 13 (Attachments: # 1 Appendix A, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 6, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 23, # 11 Exhibit 26, # 12 Exhibit 27, # 13 Exhibit 28)(14) Cover Letter) (Franklin, Yvonne). (Entered: 07/12/2017)
Entry #18 • 2017-07-12
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Elizabeth Cutri, # 2 Affidavit Certificate of Bryan S. Hales, # 3 Affidavit Certificate of James F. Hurst, # 4 Affidavit Certificate of James H. McConnell, # 5 Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne). (Entered: 08/01/2017)
Entry #19 • 2017-08-01
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Elizabeth Cutri, # 2 Affidavit Certificate of Bryan S. Hales, # 3 Affidavit Certificate of James F. Hurst, # 4 Affidavit Certificate of James H. McConnell, # 5 Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne). (Entered: 08/01/2017)
Entry #19 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Elizabeth Cutri, # 2 Affidavit Certificate of Bryan S. Hales, # 3 Affidavit Certificate of James F. Hurst, # 4 Affidavit Certificate of James H. McConnell, # 5 Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne). (Entered: 08/01/2017)
Entry #19 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Elizabeth Cutri, # 2 Affidavit Certificate of Bryan S. Hales, # 3 Affidavit Certificate of James F. Hurst, # 4 Affidavit Certificate of James H. McConnell, # 5 Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne). (Entered: 08/01/2017)
Entry #19 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Elizabeth Cutri, # 2 Affidavit Certificate of Bryan S. Hales, # 3 Affidavit Certificate of James F. Hurst, # 4 Affidavit Certificate of James H. McConnell, # 5 Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne). (Entered: 08/01/2017)
Entry #19 • 2017-08-01
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane Filing fee: $ 500, receipt number 0101-6734750 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Elizabeth Cutri, # 2 Affidavit Certificate of Bryan S. Hales, # 3 Affidavit Certificate of James F. Hurst, # 4 Affidavit Certificate of James H. McConnell, # 5 Affidavit Certificate of Ryan Kane)(Martin, Andrea) (Attachment 4 & 5 replaced on 8/1/2017)with correct documents. (Franklin, Yvonne). (Entered: 08/01/2017)
Entry #19 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Charles Klein, Dan Hoang, Samuel Park Filing fee: $ 300, receipt number 0101-6734845 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Charles B. Klein, # 2 Affidavit Certificate of Dan H. Hoang, # 3 Affidavit Certificate of Samuel Park)(Martin, Andrea) (Entered: 08/01/2017)
Entry #20 • 2017-08-01
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Charles Klein, Dan Hoang, Samuel Park Filing fee: $ 300, receipt number 0101-6734845 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Charles B. Klein, # 2 Affidavit Certificate of Dan H. Hoang, # 3 Affidavit Certificate of Samuel Park)(Martin, Andrea) (Entered: 08/01/2017)
Entry #20 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Charles Klein, Dan Hoang, Samuel Park Filing fee: $ 300, receipt number 0101-6734845 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Charles B. Klein, # 2 Affidavit Certificate of Dan H. Hoang, # 3 Affidavit Certificate of Samuel Park)(Martin, Andrea) (Entered: 08/01/2017)
Entry #20 • 2017-08-01
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Charles Klein, Dan Hoang, Samuel Park Filing fee: $ 300, receipt number 0101-6734845 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Charles B. Klein, # 2 Affidavit Certificate of Dan H. Hoang, # 3 Affidavit Certificate of Samuel Park)(Martin, Andrea) (Entered: 08/01/2017)
Entry #20 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman Filing fee: $ 400, receipt number 0101-6735022 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit Certificate of Gregory L. Diskant, # 2 Affidavit Certificate of Aron Fischer, # 3 Affidavit Certificate of Andrew D. Cohen, # 4 Affidavit Certificate of Daniel A. Friedman)(Casey, Alison) (Entered: 08/01/2017)
Entry #21 • 2017-08-01
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman Filing fee: $ 400, receipt number 0101-6735022 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit Certificate of Gregory L. Diskant, # 2 Affidavit Certificate of Aron Fischer, # 3 Affidavit Certificate of Andrew D. Cohen, # 4 Affidavit Certificate of Daniel A. Friedman)(Casey, Alison) (Entered: 08/01/2017)
Entry #21 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman Filing fee: $ 400, receipt number 0101-6735022 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit Certificate of Gregory L. Diskant, # 2 Affidavit Certificate of Aron Fischer, # 3 Affidavit Certificate of Andrew D. Cohen, # 4 Affidavit Certificate of Daniel A. Friedman)(Casey, Alison) (Entered: 08/01/2017)
Entry #21 • 2017-08-01
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman Filing fee: $ 400, receipt number 0101-6735022 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit Certificate of Gregory L. Diskant, # 2 Affidavit Certificate of Aron Fischer, # 3 Affidavit Certificate of Andrew D. Cohen, # 4 Affidavit Certificate of Daniel A. Friedman)(Casey, Alison) (Entered: 08/01/2017)
Entry #21 • 2017-08-01
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman Filing fee: $ 400, receipt number 0101-6735022 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit Certificate of Gregory L. Diskant, # 2 Affidavit Certificate of Aron Fischer, # 3 Affidavit Certificate of Andrew D. Cohen, # 4 Affidavit Certificate of Daniel A. Friedman)(Casey, Alison) (Entered: 08/01/2017)
Entry #21 • 2017-08-01
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 19 Motion for Leave to Appear Pro Hac Vice Added Elizabeth Cutri, Bryan S. Hales, James F. Hurst, James H. McConnell, Ryan Kane. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 08/01/2017)
Entry #22 • 2017-08-01
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 20 Motion for Leave to Appear Pro Hac Vice Added Charles B. Klein, Dan H. Hoang, Samuel S. Park. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 08/01/2017)
Entry #23 • 2017-08-01
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 21 Motion for Leave to Appear Pro Hac Vice Added Gregory L. Diskant, Aron Fischer, Andrew D. Cohen, Daniel A. Friedman. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 08/01/2017)
Entry #24 • 2017-08-01
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #73 • 2017-08-01
1
No Actions
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #74 • 2017-08-01
1
No Actions
Motion to Dismiss
Pending / Under Review
Assented to MOTION to Seal Janssen's Opposition to Defendants' Motion to Dismiss for Lack of Standing and Supporting Exhibits by Janssen Biotech, Inc..(Casey, Alison) (Entered: 08/02/2017)
Entry #25 • 2017-08-02
1
Motion to Dismiss
Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Filed Under Seal), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5)(Casey, Alison) (Entered: 08/02/2017)
Entry #26 • 2017-08-02
1
Motion to Dismiss
Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Filed Under Seal), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5)(Casey, Alison) (Entered: 08/02/2017)
Entry #26 • 2017-08-02
2
Motion to Dismiss
Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Filed Under Seal), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5)(Casey, Alison) (Entered: 08/02/2017)
Entry #26 • 2017-08-02
2
Motion to Dismiss
Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Filed Under Seal), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5)(Casey, Alison) (Entered: 08/02/2017)
Entry #26 • 2017-08-02
2
Motion to Dismiss
Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Filed Under Seal), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5)(Casey, Alison) (Entered: 08/02/2017)
Entry #26 • 2017-08-02
2
Motion to Dismiss
Pending / Under Review
Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Filed Under Seal), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5)(Casey, Alison) (Entered: 08/02/2017)
Entry #26 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
1
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
Pending / Under Review
AFFIDAVIT of Kenneth Dow in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I (Filed Under Seal))(Casey, Alison) (Entered: 08/02/2017)
Entry #27 • 2017-08-02
2
Motion to Dismiss
Pending / Under Review
AFFIDAVIT of Katherine Amos in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 08/02/2017)
Entry #28 • 2017-08-02
1
Court Order
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting 25 Motion to Seal (Bono, Christine) (Entered: 08/07/2017)
Entry #31 • 2017-08-07
1
Court Order
Judge Mark L. Wolf: ORDER entered. Associated Cases: 1:15-cv-10698-MLW, 1:16-cv-11117-MLW, 1:17-cv-11008-MLW(Bono, Christine) (Entered: 08/07/2017)
Entry #32 • 2017-08-07
1
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
1
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
STATUS REPORT JOINT REPORT by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 08/21/2017)
Entry #33 • 2017-08-21
2
Assented to MOTION to Seal re: Joint Report by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 08/21/2017)
Entry #34 • 2017-08-21
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Irena Royzman, David Kleban Filing fee: $ 200, receipt number 0101-6768305 by Janssen Biotech, Inc.. (Attachments: # 1 Certificate of Irena Royzman, # 2 Certificate of David Kleban)(Casey, Alison) (Entered: 08/25/2017)
Entry #37 • 2017-08-25
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Irena Royzman, David Kleban Filing fee: $ 200, receipt number 0101-6768305 by Janssen Biotech, Inc.. (Attachments: # 1 Certificate of Irena Royzman, # 2 Certificate of David Kleban)(Casey, Alison) (Entered: 08/25/2017)
Entry #37 • 2017-08-25
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Irena Royzman, David Kleban Filing fee: $ 200, receipt number 0101-6768305 by Janssen Biotech, Inc.. (Attachments: # 1 Certificate of Irena Royzman, # 2 Certificate of David Kleban)(Casey, Alison) (Entered: 08/25/2017)
Entry #37 • 2017-08-25
2
Motion to Dismiss
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
1
Motion to Dismiss
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
2
Motion to Dismiss
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
2
Motion to Dismiss
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
2
Motion to Dismiss
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
2
Motion to Dismiss
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
2
Motion to Dismiss
Pending / Under Review
REPLY to Response to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing [Leave to File 30 pages granted July 10, 2017] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix B, # 2 Exhibit 32, # 3 Exhibit 33, # 4 Exhibit 34, # 5 Exhibit 35, # 6 Exhibit 36)(Martin, Andrea) (Attachment 4 replaced on 8/29/2017) (Franklin, Yvonne). (Entered: 08/25/2017)
Entry #38 • 2017-08-25
2
Motion to Dismiss
Pending / Under Review
Assented to MOTION to Seal re: Reply in support of Motion to Dismiss by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 08/25/2017)
Entry #39 • 2017-08-25
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 37 Motion for Leave to Appear Pro Hac Vice Added Irena Royzman, David Kleban. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 08/29/2017)
Entry #41 • 2017-08-29
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #117 • 2017-08-29
1
No Actions
Motion to Dismiss
Pending / Under Review
SUR-REPLY to Motion re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing (Redacted) filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 09/08/2017)
Entry #42 • 2017-09-08
1
Assented to MOTION to Seal Document 42 Sur-Reply to Motion by Janssen Biotech, Inc..(Casey, Alison) (Entered: 09/08/2017)
Entry #43 • 2017-09-08
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered granting 17 Motion to Seal (Bono, Christine) (Entered: 09/11/2017)
Entry #44 • 2017-09-11
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered granting 34 Motion to Seal (Bono, Christine) (Entered: 09/11/2017)
Entry #45 • 2017-09-11
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered granting 39 Motion to Seal (Bono, Christine) (Entered: 09/11/2017)
Entry #46 • 2017-09-11
1
NOTICE OF MANUAL FILING by Janssen Biotech, Inc. - Request for courtesy copy re: # 26 and # 42 . Forwarded to chambers. (Franklin, Yvonne) (Entered: 09/29/2017)
Entry #48 • 2017-09-29
1
NOTICE OF MANUAL FILING (Courtesy Copy) by Celltrion Healthcare Co., Ltd. (Franklin, Yvonne) (Entered: 10/02/2017)
Entry #49 • 2017-10-02
1
Court Order
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 43 Motion to Seal Document (Bono, Christine) (Entered: 10/04/2017)
Entry #50 • 2017-10-04
1
Court Order
Order on Motion to Seal Document
Entry #126 • 2017-10-04
1
No Actions
Motion to Dismiss
Pending / Under Review
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 10/12/2017 re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. Exhibits 1-7 entered. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Cutri, Diskant, Fischer, Frank, Friedman, Harris, Hurst, Kelly, Klein, Martin, Repicky) (Bono, Christine) Modified to reflect correct date on 10/30/2017 (Bono, Christine). (Entered: 10/24/2017)
Entry #61 • 2017-10-12
1
ELECTRONIC NOTICE Canceling 10/13/17 Motion Hearing. Associated Cases: 1:15-cv-10698-MLW, 1:14-cv-11613-MLW, 1:16-cv-11117-MLW, 1:17-cv-11008-MLW(Bono, Christine) (Entered: 10/13/2017)
Entry #51 • 2017-10-13
1
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
1
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
Pending / Under Review
BRIEF by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief on Judicial Estoppel. (Attachments: # 1 Appendix C, # 2 Exhibit 37, # 3 Exhibit 38, # 4 Exhibit 39, # 5 Exhibit 40, # 6 Exhibit 41, # 7 Exhibit 42, # 8 Exhibit 43, # 9 Exhibit 44, # 10 Exhibit 45, # 11 Exhibit 46, # 12 Exhibit 47, # 13 Exhibit 48)(Martin, Andrea) (Entered: 10/16/2017)
Entry #52 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
1
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Motion to Dismiss
Pending / Under Review
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Lack of Standing Supplemental Brief Regarding Judicial Estoppel filed by Janssen Biotech, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9)(Repicky, Heather) (Entered: 10/16/2017)
Entry #53 • 2017-10-16
2
Assented to MOTION to Seal Supplement Brief of Judicial Estoppel [Dkt 52] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 10/16/2017)
Entry #54 • 2017-10-16
1
NOTICE OF MANUAL FILING: Courtesy copy # 52 received and forwarded to chambers by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. (Franklin, Yvonne) (Entered: 10/18/2017)
Entry #56 • 2017-10-18
1
NOTICE OF MANUAL FILING Courtesy copy # 53 received and forwarded to chambers by Janssen Biotech, Inc. re 53 Memorandum in Opposition to Motion (Bono, Christine) (Entered: 10/19/2017)
Entry #57 • 2017-10-19
1
STATUS REPORT regarding Pending Motions by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 10/19/2017)
Entry #58 • 2017-10-19
1
STATUS REPORT Regarding Pending Motions by Janssen Biotech, Inc.. (Repicky, Heather) (Entered: 10/19/2017)
Entry #59 • 2017-10-19
1
STATUS REPORT (CORRECTED) Regarding Pending Motions by Janssen Biotech, Inc.. (Repicky, Heather) (Entered: 10/20/2017)
Entry #60 • 2017-10-20
1
Court Order
Judge Mark L. Wolf: ORDER entered. MEMORANDUM AND ORDER. (Bono, Christine)
Entry #62 • 2017-10-31
1
Court Order
Judge Mark L. Wolf: ORDER entered. (Bono, Christine) (Entered: 10/31/2017)
Entry #63 • 2017-10-31
1
ELECTRONIC NOTICE of Hearing. Telephone Conference set for 12/4/2017 02:30 PM in Courtroom 10 before Judge Mark L. Wolf. Dial-in instructions shall be provided to psrticipants separately by the Deputy Clerk. (Bono, Christine) (Entered: 10/31/2017)
Entry #64 • 2017-10-31
1
Procedural / Extension Motion
MOTION for Leave to Appear Pro Hac Vice for admission of Gregory B. Sanford Filing fee: $ 100, receipt number 0101-6880807 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Certificate of Gregory B. Sanford in Support of Assented to Motion for Admission Pro Hac Vice)(Martin, Andrea) (Entered: 11/10/2017)
Entry #65 • 2017-11-10
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice for admission of Gregory B. Sanford Filing fee: $ 100, receipt number 0101-6880807 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Certificate of Gregory B. Sanford in Support of Assented to Motion for Admission Pro Hac Vice)(Martin, Andrea) (Entered: 11/10/2017)
Entry #65 • 2017-11-10
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 65 Motion for Leave to Appear Pro Hac Vice Added Gregory B. Sanford. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 11/14/2017)
Entry #66 • 2017-11-14
1
Pleading / Complaint
ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against Janssen Biotech, Inc. by Hospira, Inc., Celltrion, Inc., Celltrion Healthcare Co., Ltd..(Martin, Andrea) (Entered: 11/14/2017)
Entry #67 • 2017-11-14
1
Motion to Stay
Pending / Under Review
MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 11/14/2017)
Entry #68 • 2017-11-14
1
Motion to Stay
Pending / Under Review
MEMORANDUM in Support re 68 MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 11/14/2017)
Entry #69 • 2017-11-14
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #169 • 2017-11-14
1
No Actions
Joint MOTION to Seal re: Joint Report and Exhibit by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 11/17/2017)
Entry #70 • 2017-11-17
1
STATUS REPORT by Celltrion Healthcare Co., Ltd.. (Attachments: # 1 Exhibit A Redacted)(Martin, Andrea) (Entered: 11/17/2017)
Entry #71 • 2017-11-17
1
STATUS REPORT by Celltrion Healthcare Co., Ltd.. (Attachments: # 1 Exhibit A Redacted)(Martin, Andrea) (Entered: 11/17/2017)
Entry #71 • 2017-11-17
2
Motion to Dismiss
Denied
Assented to MOTION for Extension of Time to December 7, 2017 to File Plaintiff's Opposition to Defendants' Motion to Certify Order Denying Motion to Dismiss and Contingent Motion for Stay Pending Appeal (Dkt. No. 68) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 11/21/2017)
Entry #73 • 2017-11-21
1
Assented to MOTION Plaintiff's Assented-to Motion to Reschedule December 4 Telephone Conference by Janssen Biotech, Inc..(Casey, Alison) (Entered: 11/27/2017)
Entry #74 • 2017-11-27
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered granting 70 Motion to Seal (Bono, Christine) (Entered: 11/28/2017)
Entry #75 • 2017-11-28
1
Court Order
Judge Mark L. Wolf: "ALLOWED. The conference shall be held on December 5, 2017, at 3:30 p.m." ENDORSED ORDER entered granting 74 Motion Reschedule Telephone Conference (Bono, Christine) (Entered: 11/28/2017)
Entry #76 • 2017-11-28
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: "As the court intends to hear argument on the motion on December 5, 2017, plaintiff's response shall be filed by 10:00 a.m. on December 4, 2017." ENDORSED ORDER entered granting in part and denying in part 73 Motion for Extension of Time (Bono, Christine) (Entered: 11/28/2017)
Entry #77 • 2017-11-28
1
ELECTRONIC NOTICE OF RESCHEDULING Telephone Conference set for 12/5/2017 03:30 PM in Courtroom 10 before Judge Mark L. Wolf. Dial-in instructions shall be provided to participants separately by the Deputy Clerk.(Bono, Christine) (Entered: 11/28/2017)
Entry #78 • 2017-11-28
1
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Extension of Time to December 7, 2017 to Respond to Defendants' Counterclaims by Janssen Biotech, Inc..(Casey, Alison) (Entered: 12/01/2017)
Entry #80 • 2017-12-01
1
Motion to Stay
MEMORANDUM in Opposition re 68 MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 12/04/2017)
Entry #81 • 2017-12-04
1
Motion to Stay
Denied
MEMORANDUM in Opposition re 68 MOTION for Leave to Appeal Motion to Certify re 28 U.S.C. § 1292(b) and Contingent Motion to Stay filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 12/04/2017)
Entry #81 • 2017-12-04
2
Motion to Dismiss
Denied
MOTION to Seal Janssen's Memorandum in Opposition to Defendants' Motion to Certify Order Denying Motion to Dismiss for Lack of Standing Under 28 U.S.C. § 1292(b) and Contingent Motion for Stay Pending Appeal (Dkt. No. 81) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 12/04/2017)
Entry #82 • 2017-12-04
1
Motion to Dismiss
Denied
NOTICE OF MANUAL FILING by Janssen Biotech, Inc. re 81 Memorandum in Opposition to Motion to Certify Order Denying Motion to Dismiss for Lack of Standing Under 28 U.S.C. § 1292(b) and Contingent Motion for Stay Pending Appeal (Casey, Alison) (Entered: 12/04/2017)
Entry #83 • 2017-12-04
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered granting 82 Motion to Seal (Bono, Christine) (Entered: 12/04/2017)
Entry #85 • 2017-12-04
1
Motion to Compel Discovery
Pending / Under Review
MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 12/05/2017)
Entry #86 • 2017-12-05
1
Motion to Compel Discovery
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
1
Motion to Compel Discovery
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
2
Motion to Compel Discovery
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
2
Motion to Compel Discovery
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
2
Motion to Compel Discovery
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
2
Motion to Compel Discovery
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
2
Motion to Compel Discovery
Pending / Under Review
MEMORANDUM in Support re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1 (includes Exhibits A-E), # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) Modified on 12/5/2017 to note include ex's. A-E(Franklin, Yvonne). (Entered: 12/05/2017)
Entry #87 • 2017-12-05
2
Motion to Compel Discovery
Pending / Under Review
MOTION to Seal re Motion to Compel [Dkt 86,87] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Additional attachment(s) added on 12/5/2017: # 1 Exhibit 4, # 2 Exhibit 6) # 3 Cover Letter) (Franklin, Yvonne). (Entered: 12/05/2017)
Entry #88 • 2017-12-05
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Benjamin F. Jackson Filing fee: $ 100, receipt number 0101-6914577 by Janssen Biotech, Inc.. (Attachments: # 1 Certificate of Benjamin F. Jackson)(Casey, Alison) (Entered: 12/05/2017)
Entry #89 • 2017-12-05
1
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Benjamin F. Jackson Filing fee: $ 100, receipt number 0101-6914577 by Janssen Biotech, Inc.. (Attachments: # 1 Certificate of Benjamin F. Jackson)(Casey, Alison) (Entered: 12/05/2017)
Entry #89 • 2017-12-05
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 89 Motion for Leave to Appear Pro Hac Vice Added Benjamin F. Jackson. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 12/05/2017)
Entry #90 • 2017-12-05
1
ELECTRONIC NOTICE OF RESCHEDULING *** AS TO TIME ONLY *** Telephone Conference set for 12/5/2017 04:00 PM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine) (Entered: 12/05/2017)
Entry #91 • 2017-12-05
1
Court Order
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Telephone Conference held on 12/5/2017. Parties shall confer and report by close of business 12/7/2017. Parties ordered to reserve 1/30/2018-2/2/2018 for court scheduling purposes. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Casey, Cohen, Cutri, Fischer, Hales, Kelly, Klein, Martin) (Bono, Christine) (Entered: 12/06/2017)
Entry #92 • 2017-12-05
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #199 • 2017-12-05
1
No Actions
Court Order
Judge Mark L. Wolf: ORDER entered. (Bono, Christine) (Entered: 12/06/2017)
Entry #93 • 2017-12-06
1
Pleading / Complaint
Plaintiff's ANSWER to Counterclaim and, COUNTERCLAIM for Patent Infringement against All Defendants by Janssen Biotech, Inc..(Casey, Alison) (Entered: 12/07/2017)
Entry #94 • 2017-12-07
1
Pleading / Complaint
Assented to MOTION to Seal Plaintiff's Answer to Counterclaim and Counterclaim for Patent Infringement against All Defendants (Dkt. No. 94) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 12/07/2017)
Entry #95 • 2017-12-07
1
STATUS REPORT Joint Submission Reporting Discovery Deadlines by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 12/07/2017)
Entry #96 • 2017-12-07
1
Transcript of Teleconference held on December 5, 2017, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 12/29/2017. Redacted Transcript Deadline set for 1/8/2018. Release of Transcript Restriction set for 3/8/2018. (Scalfani, Deborah) (Entered: 12/08/2017)
Entry #97 • 2017-12-08
1
NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Scalfani, Deborah) (Entered: 12/08/2017)
Entry #98 • 2017-12-08
1
ELECTRONIC NOTICE Setting Hearing on Motion Motion Hearing set for 1/30/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 1/31/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/1/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/2/2018 09:30 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine) (Entered: 12/08/2017)
Entry #99 • 2017-12-08
1
Court Order
Judge Mark L. Wolf: "The jointly proposed schedule concerning discovery deadlines is hereby ADOPTED. The parties shall, by January 22, 2018, confer and propose a format for the Daubert hearings." ENDORSED ORDER entered. re 96 Status Report filed by Janssen Biotech, Inc. (Bono, Christine) (Entered: 12/12/2017)
Entry #101 • 2017-12-12
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER (ALLOWED) entered granting 95 Motion to Seal. (Franklin, Yvonne) (Entered: 12/13/2017)
Entry #102 • 2017-12-13
1
MOTION to Intervene by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Exhibit A)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #103 • 2017-12-19
1
MOTION to Intervene by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Exhibit A)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #103 • 2017-12-19
2
Procedural / Extension Motion
MOTION for Leave to Appear Pro Hac Vice for admission of Robert Oakes Filing fee: $ 100, receipt number 0101-6934793 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #104 • 2017-12-19
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice for admission of Robert Oakes Filing fee: $ 100, receipt number 0101-6934793 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #104 • 2017-12-19
2
Procedural / Extension Motion
MOTION for Leave to Appear Pro Hac Vice for admission of John C. Adkisson Filing fee: $ 100, receipt number 0101-6934873 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #105 • 2017-12-19
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice for admission of John C. Adkisson Filing fee: $ 100, receipt number 0101-6934873 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #105 • 2017-12-19
2
Procedural / Extension Motion
MOTION for Leave to Appear Pro Hac Vice for admission of Bruce M. Gagala Filing fee: $ 100, receipt number 0101-6934883 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #106 • 2017-12-19
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice for admission of Bruce M. Gagala Filing fee: $ 100, receipt number 0101-6934883 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #106 • 2017-12-19
2
Procedural / Extension Motion
MOTION for Leave to Appear Pro Hac Vice for admission of John Kilyk, Jr. Filing fee: $ 100, receipt number 0101-6934891 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #107 • 2017-12-19
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice for admission of John Kilyk, Jr. Filing fee: $ 100, receipt number 0101-6934891 by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Entered: 12/19/2017)
Entry #107 • 2017-12-19
2
Motion to Compel Discovery
Pending / Under Review
RESPONSE to Motion re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 12/19/2017)
Entry #108 • 2017-12-19
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 104 Motion for Leave to Appear Pro Hac Vice Added Robert M. Oakes. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 12/20/2017)
Entry #109 • 2017-12-20
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 105 Motion for Leave to Appear Pro Hac Vice Added John C. Adkisson. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 12/20/2017)
Entry #110 • 2017-12-20
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 106 Motion for Leave to Appear Pro Hac Vice Added Bruce M. Gagala. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 12/20/2017)
Entry #111 • 2017-12-20
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 107 Motion for Leave to Appear Pro Hac Vice Added John Kilyk, Jr.. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 12/20/2017)
Entry #112 • 2017-12-20
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #224 • 2017-12-20
1
No Actions
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #225 • 2017-12-20
1
No Actions
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #226 • 2017-12-20
1
No Actions
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #227 • 2017-12-20
1
No Actions
Motion to Compel Discovery
Joint MOTION for Leave to File Reply and Sur-Reply Briefs and Proposed Schedules re Motion to Compel Third Party Documents by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Text of Proposed Order)(Martin, Andrea) (Entered: 12/21/2017)
Entry #113 • 2017-12-21
1
Motion to Compel Discovery
Pending / Under Review
Joint MOTION for Leave to File Reply and Sur-Reply Briefs and Proposed Schedules re Motion to Compel Third Party Documents by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Text of Proposed Order)(Martin, Andrea) (Entered: 12/21/2017)
Entry #113 • 2017-12-21
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Saunek Desei and Noah Frank Filing fee: $ 200, receipt number 0101-6938525 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Saunak Desei, # 2 Affidavit Certificate of Noah Frank)(Martin, Andrea) (Entered: 12/21/2017)
Entry #114 • 2017-12-21
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Saunek Desei and Noah Frank Filing fee: $ 200, receipt number 0101-6938525 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Saunak Desei, # 2 Affidavit Certificate of Noah Frank)(Martin, Andrea) (Entered: 12/21/2017)
Entry #114 • 2017-12-21
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Saunek Desei and Noah Frank Filing fee: $ 200, receipt number 0101-6938525 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit Certificate of Saunak Desei, # 2 Affidavit Certificate of Noah Frank)(Martin, Andrea) (Entered: 12/21/2017)
Entry #114 • 2017-12-21
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 114 Motion for Leave to Appear Pro Hac Vice Added Saunak Desai, Noah Frank. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 12/21/2017)
Entry #115 • 2017-12-21
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #234 • 2017-12-21
1
No Actions
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered (ALLOWED)granting 103 Motion to Intervene. (Franklin, Yvonne) (Entered: 12/27/2017)
Entry #116 • 2017-12-27
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ENDORSED ORDER entered (ALLOWED) granting 113 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Franklin, Yvonne) (Entered: 12/27/2017)
Entry #117 • 2017-12-27
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER SCHEDULING FOR BRIEFING entered and (ALLOWED) granting 113 . (Franklin, Yvonne) (Entered: 12/27/2017)
Entry #118 • 2017-12-27
1
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
1
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
Motion to Compel Discovery
Pending / Under Review
MEMORANDUM in Opposition re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (Attachments: # 1 Affidavit)(shmuel, Jenny) (Additional attachment(s) added on 12/28/2017: # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit A, # 9 Exhibit B, # 10 Exhibit C, # 11 Exhibit D, # 12 Exhibit E, # 13 Exhibit F) and (Attachment 1 replaced and Modified on 12/28/2017 to separate documents and exhibits using CD provided by filer. (Franklin, Yvonne). (Entered: 12/27/2017)
Entry #119 • 2017-12-27
2
ELECTRONIC NOTICE issued requesting courtesy copy for 119 Memorandum in Opposition to Motion. Counsel who filed this document are requested to submit a courtesy copy of this document separating the exhibits. Also include a CD (with each exhibit as a separate attachment) and submit to the Clerk's Office by January 4, 2018. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Franklin, Yvonne) (Entered: 12/28/2017)
Entry #120 • 2017-12-28
1
Notice of correction to docket made by Court staff. Correction: D.E. 119, Exhibit 1 corrected because: entire exhibit filed as one document. All exhibits should have been separated and has been corrected with CD provided by filer. In the future filer should separate and file exhibits as separate attachments. Counsel is reminded to review the local rules and the attorney handbook when filing documents with the Court by accessing our web page, at www.mad.uscourts.gov under CM/ECF E-Filing. Yvonne Franklin, Docket Clerk (Franklin, Yvonne) (Entered: 12/28/2017)
Entry #121 • 2017-12-28
1
Motion to Dismiss
Pending / Under Review
MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 12/28/2017)
Entry #122 • 2017-12-28
1
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
1
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
Pending / Under Review
MEMORANDUM in Support re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Martin, Andrea) (Entered: 12/28/2017)
Entry #123 • 2017-12-28
2
Motion to Dismiss
Pending / Under Review
MOTION to Seal re Motion to Dismiss Dkt 123 et seq by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 12/28/2017)
Entry #124 • 2017-12-28
1
Motion to Compel Discovery
Pending / Under Review
REPLY to Response to 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS [Leave to File Granted 12/27/17] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc., Janssen Biotech, Inc.. (Martin, Andrea) (Entered: 12/29/2017)
Entry #126 • 2017-12-29
1
Motion to Compel Discovery
Pending / Under Review
MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 12/29/2017)
Entry #127 • 2017-12-29
1
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
1
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
Pending / Under Review
MEMORANDUM in Support re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 12/29/2017)
Entry #128 • 2017-12-29
2
Motion to Compel Discovery
Pending / Under Review
MOTION for Extension of Time to 1/16/18 to File Response/Reply as to 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS [UNOPPOSED] by Biogen, Inc..(Barlow, Joshua) (Entered: 01/04/2018)
Entry #129 • 2018-01-04
1
Motion to Compel Discovery
Pending / Under Review
SUR-REPLY to Motion re 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS filed by Samsung Bioepis, Co., Ltd.. (shmuel, Jenny) (Entered: 01/05/2018)
Entry #130 • 2018-01-05
1
Motion to Compel Discovery
Pending / Under Review
Judge Mark L. Wolf: ENDORSED ORDER entered and (ALLOWED) granting 129 Motion for Extension of Time to File Response re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS Responses due by 1/16/2018 (Franklin, Yvonne) (Entered: 01/08/2018)
Entry #131 • 2018-01-08
1
Motion to Dismiss
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
1
Motion to Dismiss
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
2
Motion to Dismiss
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
2
Motion to Dismiss
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
2
Motion to Dismiss
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
2
Motion to Dismiss
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
2
Motion to Dismiss
Pending / Under Review
Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal))(Casey, Alison) (Main Document 132 replaced on 3/8/2018)(Franklin, Yvonne). Modified on 3/8/2018 with corrected version with further redaction provided by filer. (Franklin, Yvonne). (Entered: 01/11/2018)
Entry #132 • 2018-01-11
2
Motion to Dismiss
Pending / Under Review
Assented to MOTION to Seal Opposition re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 01/11/2018)
Entry #133 • 2018-01-11
1
Court Order
MOTION Order to Appear Relief from Order to Appear by Celltrion Healthcare Co., Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 01/12/2018)
Entry #135 • 2018-01-12
1
Court Order
MOTION Order to Appear Relief from Order to Appear by Celltrion Healthcare Co., Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 01/12/2018)
Entry #135 • 2018-01-12
2
Court Order
MOTION Order to Appear Relief from Order to Appear by Celltrion Healthcare Co., Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 01/12/2018)
Entry #135 • 2018-01-12
2
Court Order
MOTION Relief from Order to Appear CORRECTED from Dkt 135 [Relief Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 01/12/2018)
Entry #136 • 2018-01-12
1
Court Order
MOTION Relief from Order to Appear CORRECTED from Dkt 135 [Relief Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 01/12/2018)
Entry #136 • 2018-01-12
2
Court Order
MOTION Relief from Order to Appear CORRECTED from Dkt 135 [Relief Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 01/12/2018)
Entry #136 • 2018-01-12
2
MOTION to Modify Case Schedule by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2)(Martin, Andrea) (Entered: 01/15/2018)
Entry #137 • 2018-01-15
1
MOTION to Modify Case Schedule by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2)(Martin, Andrea) (Entered: 01/15/2018)
Entry #137 • 2018-01-15
2
MOTION to Modify Case Schedule by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2)(Martin, Andrea) (Entered: 01/15/2018)
Entry #137 • 2018-01-15
2
MOTION to Modify Case Schedule by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2)(Martin, Andrea) (Entered: 01/15/2018)
Entry #137 • 2018-01-15
2
Notice of correction to docket made by Court staff. Correction: D.E. 135 corrected because: Motion terminated as main document attached by filer in error. (Franklin, Yvonne) (Entered: 01/16/2018)
Entry #138 • 2018-01-16
1
Court Order
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 136 Motion for Relief from Order to Appear. (Bono, Christine) (Entered: 01/16/2018)
Entry #139 • 2018-01-16
1
Assented to MOTION to Seal [Previously filed as Dkt 124, refiled to reflect Plaintiff assent] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 01/16/2018)
Entry #140 • 2018-01-16
1
Motion to Compel Discovery
Pending / Under Review
Opposition re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Biogen, Inc.. (Barlow, Joshua) (Entered: 01/16/2018)
Entry #141 • 2018-01-16
1
Motion to Compel Discovery
Pending / Under Review
AFFIDAVIT of John Ruesch in Opposition re 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS filed by Biogen, Inc.. (Barlow, Joshua) (Entered: 01/16/2018)
Entry #142 • 2018-01-16
1
Court Order
Order on Motion for Miscellaneous Relief
Entry #312 • 2018-01-16
1
No Actions
RESPONSE to Motion re 137 MOTION to Modify Case Schedule filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C)(Casey, Alison) (Entered: 01/18/2018)
Entry #143 • 2018-01-18
1
RESPONSE to Motion re 137 MOTION to Modify Case Schedule filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C)(Casey, Alison) (Entered: 01/18/2018)
Entry #143 • 2018-01-18
2
RESPONSE to Motion re 137 MOTION to Modify Case Schedule filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C)(Casey, Alison) (Entered: 01/18/2018)
Entry #143 • 2018-01-18
2
RESPONSE to Motion re 137 MOTION to Modify Case Schedule filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C)(Casey, Alison) (Entered: 01/18/2018)
Entry #143 • 2018-01-18
2
Assented to MOTION to Seal Document 143 Response to Motion (Exhibit A to Janssen's Response to Defendants' Motion to Modify Case Schedule) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 01/18/2018)
Entry #144 • 2018-01-18
1
Motion to Dismiss
MOTION for Leave to File [Unopposed] Leave to File Reply In Support of Motion to Dismiss Counterclaims by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit A [Proposed Reply])(Martin, Andrea) (Entered: 01/19/2018)
Entry #145 • 2018-01-19
1
Motion to Dismiss
Pending / Under Review
MOTION for Leave to File [Unopposed] Leave to File Reply In Support of Motion to Dismiss Counterclaims by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit A [Proposed Reply])(Martin, Andrea) (Entered: 01/19/2018)
Entry #145 • 2018-01-19
2
STATUS REPORT Joint Report re: Outline for Daubert Hearings scheduled for 1/30/18 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 01/22/2018)
Entry #147 • 2018-01-22
1
Motion to Compel Discovery
Pending / Under Review
Letter/request (non-motion) from Counsel for Biogen RE: Hearing Date on Defendants Motion to Compel Biogens Compliance with Subpoenas (Dkt. No. 127) . (Barlow, Joshua) (Entered: 01/24/2018)
Entry #148 • 2018-01-24
1
Court Order
Judge Mark L. Wolf: ORDER entered, re 147 Status Report. See attached Order. (Bono, Christine) (Entered: 01/25/2018)
Entry #149 • 2018-01-25
1
ELECTRONIC NOTICE Resetting (*** AS TO TIME ONLY ***) Hearing on Motions: Motion Hearing set for 1/30/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 1/31/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/1/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. Motion Hearing set for 2/2/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine) (Entered: 01/25/2018)
Entry #150 • 2018-01-25
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting 124 Motion to Seal. (Franklin, Yvonne) (Entered: 01/26/2018)
Entry #151 • 2018-01-26
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting 133 Motion to Seal. (Franklin, Yvonne) (Entered: 01/26/2018)
Entry #152 • 2018-01-26
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting 144 Motion to Seal Document. (Franklin, Yvonne) (Entered: 01/26/2018)
Entry #153 • 2018-01-26
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ENDORSED ORDER entered and ALLOWED granting 145 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Franklin, Yvonne) (Entered: 01/26/2018)
Entry #154 • 2018-01-26
1
Motion to Dismiss
REPLY to Response to 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) [Leave to File Granted 1/26/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19)(Martin, Andrea) (Entered: 01/26/2018)
Entry #155 • 2018-01-26
1
Motion to Dismiss
REPLY to Response to 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) [Leave to File Granted 1/26/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19)(Martin, Andrea) (Entered: 01/26/2018)
Entry #155 • 2018-01-26
2
Motion to Dismiss
Pending / Under Review
REPLY to Response to 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) [Leave to File Granted 1/26/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19)(Martin, Andrea) (Entered: 01/26/2018)
Entry #155 • 2018-01-26
2
Motion to Strike / Sanctions
Assented to MOTION for Leave to File Janssen's Surreply in Opposition to Defendants' Motion to Strike or Dismiss Janssen's Counterclaims Under 35 U.S.C. s. 271(f)(1) by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Janssen's Surreply))(Casey, Alison) (Entered: 01/26/2018)
Entry #156 • 2018-01-26
1
Motion to Strike / Sanctions
Pending / Under Review
Assented to MOTION for Leave to File Janssen's Surreply in Opposition to Defendants' Motion to Strike or Dismiss Janssen's Counterclaims Under 35 U.S.C. s. 271(f)(1) by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Janssen's Surreply))(Casey, Alison) (Entered: 01/26/2018)
Entry #156 • 2018-01-26
2
Motion to Strike / Sanctions
Pending / Under Review
Assented to MOTION to Seal Janssen's Surreply in Opposition to Defendants' Motion to Strike or Dismiss Janssen's Counterclaims Under 35 U.S.C. s. 271(f)(1) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 01/26/2018)
Entry #157 • 2018-01-26
1
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 1/30/2018. Plaintiff calls Dr. Michael Butler and Dr. Florian Wurm for testimony. Exhibits 1-8 entered. Hearing shall resume at 10:00 a.m. on 1/31/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Cohen, Fischer, Casey, Harris, Hurst, Hales, Sanford, McConnell, Klein, Kelly, Desai, Meyers, Martin) (Bono, Christine) (Entered: 01/31/2018)
Entry #159 • 2018-01-30
1
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 1/31/2018. Exhibits 9-12 entered. Hearing shall resume at 11:00 a.m. on 2/1/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Davies, Casey, Harris, Hurst, Hales, Desai, Sanford, McConnell, Cutri, Klein, Kelly, Martin, Meyers) (Bono, Christine) (Entered: 02/01/2018)
Entry #160 • 2018-01-31
1
ELECTRONIC NOTICE Resetting Hearing on Motion *** TIME CHANGE ONLY *** Motion Hearing set for 2/1/2018 11:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine) (Entered: 02/01/2018)
Entry #161 • 2018-02-01
1
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 2/1/2018. Exhibits 13-14 entered. Hearing shall resume at 10:00 a.m. on 2/2/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Cohen, Casey, Harris, Hurst, Hales, Desai, Sanford, Cutri, Klein, Kelly, Martin, Meyers) (Bono, Christine) (Entered: 02/01/2018)
Entry #162 • 2018-02-01
1
ELECTRONIC NOTICE Setting Motion Hearing. Motion Hearing to resume 2/2/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine) (Entered: 02/01/2018)
Entry #163 • 2018-02-01
1
Court Order
Recommendations for Scheduling Order Defendants Proposed Modified Schedule. (Martin, Andrea) (Entered: 02/02/2018)
Entry #164 • 2018-02-02
1
Court Order
Recommendations for Scheduling Order Janssen's Position on Case Schedule. (Casey, Alison) (Entered: 02/02/2018)
Entry #165 • 2018-02-02
1
Court Order
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Hearing concluded on 2/2/2018. Parties are ordered to reserve 6/11/2018-6/29/2018 for pending motions and 7/30/2018-10/1/2018 for trial. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Davies, Casey, Harris, Hurst, Hales, Sanford, Cutri, Martin, Meyers) (Bono, Christine) (Entered: 02/05/2018)
Entry #166 • 2018-02-02
1
Motion to Strike / Sanctions
Pending / Under Review
Judge Mark L. Wolf: "It is hereby ORDERED that: 1. A hearing on the motions to compel Janssen Biotech, Inc. ("Janssen") and Biogen, Inc. ("Biogen") to produce documents and a Biogen witness concerning the media used to produce Renflexis (Docket Nos. 86 and 127) shall be held on February 16, 2018, at 10:00 a.m. 2. The parties shall also be prepared to argue the defendants' motion to strike or dismiss Janssen's counterclaims in reply under 35 U.S.C. §271(f) (Docket No. 122)." ORDER entered. (Bono, Christine) (Entered: 02/08/2018)
Entry #167 • 2018-02-08
1
Motion to Dismiss
Pending / Under Review
ELECTRONIC NOTICE Setting Hearing on Motion 127 MOTION to Compel THIRD PARTY BIOGEN TO COMPLY WITH SUBPOENAS, 86 MOTION to Compel PRODUCTION OF THIRD-PARTY DOCUMENTS, 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) : Motion Hearing set for 2/16/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine) (Entered: 02/08/2018)
Entry #168 • 2018-02-08
1
Motion to Dismiss
Pending / Under Review
SUR-REPLY to Motion re 122 MOTION to Dismiss to Strike or Dismiss Janssen's "Counterclaims under 35 U.S.C. § 271(f) (Redacted Version - Leave to File Granted 1/30/18) filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 02/09/2018)
Entry #169 • 2018-02-09
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 54 Motion to Seal; granting 80 Motion for Extension of Time; granting 88 Motion to Seal; granting 140 Motion to Seal; granting 156 Motion for Leave to File Document ; If counsel has not already done so, counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; granting 157 Motion to Seal (Bono, Christine) (Entered: 02/09/2018)
Entry #170 • 2018-02-09
1
Court Order
RESPONSE TO COURT ORDER by Janssen Biotech, Inc. (Joint Submission regarding Janssen's motion to limit the testimony of Michael Glacken Sc. D. with respect to infringement). (Attachments: # 1 Exhibit A (Janssen's Submission - Filed Under Seal), # 2 Exhibit B (Defendants' Submission - Filed Under Seal))(Casey, Alison) (Entered: 02/09/2018)
Entry #171 • 2018-02-09
1
Court Order
RESPONSE TO COURT ORDER by Janssen Biotech, Inc. (Joint Submission regarding Janssen's motion to limit the testimony of Michael Glacken Sc. D. with respect to infringement). (Attachments: # 1 Exhibit A (Janssen's Submission - Filed Under Seal), # 2 Exhibit B (Defendants' Submission - Filed Under Seal))(Casey, Alison) (Entered: 02/09/2018)
Entry #171 • 2018-02-09
2
Court Order
RESPONSE TO COURT ORDER by Janssen Biotech, Inc. (Joint Submission regarding Janssen's motion to limit the testimony of Michael Glacken Sc. D. with respect to infringement). (Attachments: # 1 Exhibit A (Janssen's Submission - Filed Under Seal), # 2 Exhibit B (Defendants' Submission - Filed Under Seal))(Casey, Alison) (Entered: 02/09/2018)
Entry #171 • 2018-02-09
2
Court Order
Proposed Document(s) submitted by Janssen Biotech, Inc.. Document received: Proposed Scheduling Order. (Attachments: # 1 Exhibit A (Proposed Scheduling Order))(Casey, Alison) (Entered: 02/09/2018)
Entry #172 • 2018-02-09
1
Court Order
Proposed Document(s) submitted by Janssen Biotech, Inc.. Document received: Proposed Scheduling Order. (Attachments: # 1 Exhibit A (Proposed Scheduling Order))(Casey, Alison) (Entered: 02/09/2018)
Entry #172 • 2018-02-09
2
Procedural / Extension Motion
Order on Motion for Extension of Time AND Order on Motion for Leave to File Document AND Order on Motion to Seal AND Order on Motion to Seal AND Order on Motion to Seal AND Order on Motion to Seal
Entry #351 • 2018-02-09
1
No Actions
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Edgar Haug and Sandra Kuzmich Filing fee: $ 200, receipt number 0101-7006052 by Biogen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Barlow, Joshua) (Entered: 02/12/2018)
Entry #174 • 2018-02-12
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Edgar Haug and Sandra Kuzmich Filing fee: $ 200, receipt number 0101-7006052 by Biogen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Barlow, Joshua) (Entered: 02/12/2018)
Entry #174 • 2018-02-12
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Edgar Haug and Sandra Kuzmich Filing fee: $ 200, receipt number 0101-7006052 by Biogen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Barlow, Joshua) (Entered: 02/12/2018)
Entry #174 • 2018-02-12
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 174 Motion for Leave to Appear Pro Hac Vice Added Sandra Kuzmich, Edgar H. Haug. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 02/13/2018)
Entry #175 • 2018-02-13
1
Procedural / Extension Motion
Order on Motion for Leave to Appear
Entry #356 • 2018-02-13
1
No Actions
Court Order
Judge Mark L. Wolf: ORDER entered. SCHEDULING ORDER. (Bono, Christine) (Entered: 02/15/2018)
Entry #176 • 2018-02-15
1
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 2/16/2018. Exhibits 1-3 entered. (Court Reporter: Debra Joyce at joycedebra@gmail.com.)(Attorneys present: Diskant, Casey, Jackson, Quirk, Hales, Cutri, Klein, Martin, Kelly, Shmuel, Adkisson, Gagala, Haug, Barlow, Kuzmich) (Bono, Christine) (Entered: 02/21/2018)
Entry #184 • 2018-02-16
1
Transcript of Hearing held on January 30, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah) (Entered: 02/20/2018)
Entry #177 • 2018-02-20
1
Transcript of Hearing held on January 31, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah) (Entered: 02/20/2018)
Entry #178 • 2018-02-20
1
Transcript of Hearing held on February 1, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah) (Entered: 02/20/2018)
Entry #179 • 2018-02-20
1
Transcript of Hearing held on February 2, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 3/13/2018. Redacted Transcript Deadline set for 3/23/2018. Release of Transcript Restriction set for 5/21/2018. (Scalfani, Deborah) (Entered: 02/20/2018)
Entry #180 • 2018-02-20
1
NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Scalfani, Deborah) (Entered: 02/20/2018)
Entry #181 • 2018-02-20
1
Motion to Compel Discovery
Pending / Under Review
Judge Mark L. Wolf: ORDER entered denying 86 Motion to Compel; denying 127 Motion to Compel. (Bono, Christine) (Entered: 02/20/2018)
Entry #182 • 2018-02-20
1
Motion to Dismiss
Denied
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that the Motion to Dismiss orStrike Janssen's Counterclaims under 35 U.S.C. §271(f) (Docket No.122) is DENIED." ORDER entered. MEMORANDUM AND ORDER. (Bono, Christine) (Entered: 02/21/2018)
Entry #183 • 2018-02-20
1
STATUS REPORT JOINT REPORT REGARDING DISCOVERY DISPUTES by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 02/21/2018)
Entry #185 • 2018-02-21
1
Court Order
Judge Mark L. Wolf: "The hearing tentatively scheduled for February 23, 2018 is hereby CANCELLED." ENDORSED ORDER entered. re 185 Status Report filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine) (Entered: 02/22/2018)
Entry #186 • 2018-02-22
1
Transcript of Motion Hearing held on February 16, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Debra Joyce at joycedebra@gmail.com Redaction Request due 3/16/2018. Redacted Transcript Deadline set for 3/26/2018. Release of Transcript Restriction set for 5/24/2018. (Scalfani, Deborah) (Main Document 187 replaced on 2/23/2018) (Scalfani, Deborah). (Entered: 02/23/2018)
Entry #187 • 2018-02-23
1
NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Scalfani, Deborah) (Entered: 02/23/2018)
Entry #188 • 2018-02-23
1
NOTICE of Withdrawal of Appearance by Andrea L. Martin Notice of Withdrawal of Saunak Desai from Representing Defendants (Martin, Andrea) (Entered: 02/23/2018)
Entry #189 • 2018-02-23
1
STATUS REPORT JOINT REPORT REGARDING FACT WITNESS DEPOSITIONS by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 02/27/2018)
Entry #190 • 2018-02-27
1
Court Order
Judge Mark L. Wolf: "ALLOWED." ELECTRONIC ORDER entered. re 190 Status Report filed by Janssen Biotech, Inc. (Bono, Christine) (Bono, Christine). (Entered: 02/28/2018)
Entry #191 • 2018-02-28
1
Motion to Compel Discovery
Pending / Under Review
MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents by Janssen Biotech, Inc..(Casey, Alison) (Entered: 02/28/2018)
Entry #192 • 2018-02-28
1
Motion to Compel Discovery
Pending / Under Review
MEMORANDUM in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents (Redacted) filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 02/28/2018)
Entry #193 • 2018-02-28
1
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
1
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
Pending / Under Review
AFFIDAVIT in Support re 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents . (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L-P (Filed Under Seal))(Casey, Alison) (Entered: 02/28/2018)
Entry #194 • 2018-02-28
2
Motion to Compel Discovery
Pending / Under Review
MOTION to Seal Janssen's Memorandum in Support of its Motion to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents and Certain Memorandum Exhibits by Janssen Biotech, Inc..(Casey, Alison) (Main Document 195 replaced on 3/8/2018) (Franklin, Yvonne). Modified on 3/8/2018 with corrected version provided by filer. (Franklin, Yvonne). (Entered: 02/28/2018)
Entry #195 • 2018-02-28
1
Court Order
Order
Entry #389 • 2018-02-28
1
No Actions
Pleading / Complaint
ANSWER to Counterclaim Defendants' Answer to Plaintiff's Counterclaims under 35 USC 271(f)(1) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 03/02/2018)
Entry #196 • 2018-03-02
1
Pleading / Complaint
Assented to MOTION to Seal Defendants Answer to Janssen Counterclaim by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 03/02/2018)
Entry #197 • 2018-03-02
1
Motion to Compel Discovery
Pending / Under Review
MOTION for Extension of Time to 3/21/18 to Oppose Motion to Compel [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 03/07/2018)
Entry #201 • 2018-03-07
1
STATUS REPORT And Request to Reschedule Discovery Dispute Call by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 03/07/2018)
Entry #202 • 2018-03-07
1
STATUS REPORT And Request to Reschedule Discovery Dispute Call by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 03/07/2018)
Entry #202 • 2018-03-07
2
STATUS REPORT And Request to Reschedule Discovery Dispute Call by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 03/07/2018)
Entry #202 • 2018-03-07
2
STATUS REPORT And Request to Reschedule Discovery Dispute Call by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 03/07/2018)
Entry #202 • 2018-03-07
2
Notice of correction to docket made by Court staff. Correction: D.E. 132 and 195 corrected because: # 132 replaced with corrected version. # 195 replaced with corrected version, both provided by filer. (Franklin, Yvonne) (Entered: 03/08/2018)
Entry #203 • 2018-03-08
1
Response by Janssen Biotech, Inc. to 202 Status Report . (Attachments: # 1 Exhibit 1)(Casey, Alison) (Entered: 03/09/2018)
Entry #204 • 2018-03-09
1
Response by Janssen Biotech, Inc. to 202 Status Report . (Attachments: # 1 Exhibit 1)(Casey, Alison) (Entered: 03/09/2018)
Entry #204 • 2018-03-09
2
Court Order
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting 195 Motion to Seal (Bono, Christine) (Entered: 03/12/2018)
Entry #205 • 2018-03-12
1
Court Order
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting 197 Motion to Seal (Bono, Christine) (Entered: 03/12/2018)
Entry #206 • 2018-03-12
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting 201 Motion for Extension of Time (Bono, Christine) (Entered: 03/12/2018)
Entry #207 • 2018-03-12
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Extension of Time to March 23, 2018 to File Expert Report [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 03/13/2018)
Entry #208 • 2018-03-13
1
ELECTRONIC NOTICE of Hearing. Telephone Conference set for 3/26/2018 02:15 PM in Courtroom 10 before Judge Mark L. Wolf. Dial-in instructions shall be provided to participants separately by the Deputy Clerk. (Bono, Christine) (Entered: 03/15/2018)
Entry #209 • 2018-03-15
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 208 Motion for Extension of Time (Bono, Christine) (Entered: 03/15/2018)
Entry #210 • 2018-03-15
1
Procedural / Extension Motion
Order on Motion for Extension of Time
Entry #406 • 2018-03-15
1
No Actions
STIPULATION Joint Stipulation Regarding Expert Reports by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 03/16/2018)
Entry #211 • 2018-03-16
1
Motion to Compel Discovery
Pending / Under Review
Assented to MOTION to Withdraw 192 MOTION to Compel the Production of Unredacted Versions of Non-Privileged Celltrion Documents by Janssen Biotech, Inc..(Casey, Alison) (Entered: 03/20/2018)
Entry #212 • 2018-03-20
1
Court Order
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered. re 211 Stipulation filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine) (Entered: 03/20/2018)
Entry #213 • 2018-03-20
1
Court Order
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered granting 212 Motion to Withdraw (Bono, Christine) (Entered: 03/20/2018)
Entry #214 • 2018-03-20
1
Procedural / Extension Motion
Pending / Under Review
STIPULATION re 210 Order on Motion for Extension of Time Re: Expert Report of Dr. Leonard to March 29, 2018 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 03/22/2018)
Entry #215 • 2018-03-22
1
Court Order
Judge Mark L. Wolf: "ALLOWED." ENDORSED ORDER entered. re 215 Stipulation filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine) (Entered: 03/26/2018)
Entry #216 • 2018-03-26
1
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Telephone Conference held on 3/26/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Repicky, Cutri, Sanford, Martin) (Bono, Christine) (Entered: 03/26/2018)
Entry #217 • 2018-03-26
1
Court Order
Denied
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' request to compel plaintiff to produce "emails and email attachments related to Janssen's communications with its customers about Remicade pricing, discounts, rebates, and reimbursement" in addition to the documents plaintiff has agreed to produce, Docket No. 202 at 1, is DENIED. 2. The parties shall, by April 4, 2018, file redacted copies of the expert reports of Drs. Florian Wurm, Michael Butler, and Michael Glacken for the public record." ORDER entered. re 202 Status Report filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. (Bono, Christine) (Entered: 03/26/2018)
Entry #218 • 2018-03-26
1
Transcript of Telephone Conference held on March 26, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 4/20/2018. Redacted Transcript Deadline set for 4/30/2018. Release of Transcript Restriction set for 6/28/2018. (Scalfani, Deborah) (Entered: 03/30/2018)
Entry #219 • 2018-03-30
1
NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Scalfani, Deborah) (Entered: 03/30/2018)
Entry #220 • 2018-03-30
1
Motion to Compel Discovery
Order on Motion for Modification AND Order on Motion to Compel
Entry #417 • 2018-04-02
1
No Actions
Motion to Compel Discovery
Judge Mark L. Wolf: ELECTRONIC ORDER entered finding as moot 137 Motion for Modification; withdrawing 192 Motion to Compel, per 214 . (Bono, Christine)
Entry #418 • 2018-04-02
1
No Actions
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
1
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
2
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
2
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
2
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
2
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
2
REDACTION and Notice of Filing of Parties' Expert Reports byJanssen Biotech, Inc.. (Attachments: # 1 Opening Infringement Expert Report of Professor Florian M. Wurm, # 2 Lab Report of Professor Florian M. Wurm, # 3 Opening Infringement Expert Report of Professor Michael Butler, # 4 Opening Expert Report of Michael Glacken, Ph.D. Regarding Invalidity, # 5 Rebuttal Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement, # 6 Reply Expert Report of Michael Glacken, Sc.D. Regarding Non-Infringement)(Casey, Alison) (Entered: 04/03/2018)
Entry #221 • 2018-04-03
2
Procedural / Extension Motion
MOTION for Leave to File Ensnarement Summary Judgment, for 30 page brief, hearing and to set briefing schedule [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 04/03/2018)
Entry #222 • 2018-04-03
1
Procedural / Extension Motion
MOTION for Leave to File Ensnarement Summary Judgment, for 30 page brief, hearing and to set briefing schedule [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 04/03/2018)
Entry #222 • 2018-04-03
2
Procedural / Extension Motion
Pending / Under Review
MOTION for Leave to File Ensnarement Summary Judgment, for 30 page brief, hearing and to set briefing schedule [Unopposed] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 04/03/2018)
Entry #222 • 2018-04-03
2
MOTION to Seal re: Ensnarement Summary Judgment Memorandum by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 04/03/2018)
Entry #223 • 2018-04-03
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Judge Mark L. Wolf: ENDORSED ORDER entered ALLOWED 222 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. As plaintiff does not oppose the filing of a motion for summary judgment or the briefing schedule, this Motion is hereby ALLOWED and the proposed briefing schedule is ADOPTED. (Franklin, Yvonne) (Entered: 04/04/2018)
Entry #224 • 2018-04-04
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered ALLOWED 223 Motion to Seal. (Franklin, Yvonne) (Entered: 04/04/2018)
Entry #225 • 2018-04-04
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 04/06/2018)
Entry #226 • 2018-04-06
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
MEMORANDUM in Support re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6 (Redacted), # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29)(Martin, Andrea) Modified on 4/6/2018 exhibit 6 replaced with redacted version per filer. (Franklin, Yvonne). (Attachment 6 replaced on 4/6/2018) (Franklin, Yvonne). (Entered: 04/06/2018)
Entry #227 • 2018-04-06
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 04/06/2018)
Entry #228 • 2018-04-06
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
ADDENDUM re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] APPENDIX A to Memorandum and Statement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 04/06/2018)
Entry #229 • 2018-04-06
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
ADDENDUM re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] APPENDIX B to Memorandum and Statement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 04/06/2018)
Entry #230 • 2018-04-06
1
Assented to MOTION to Seal re: Ensnarement Summary Judgment Facts and Exhibits by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 04/06/2018)
Entry #231 • 2018-04-06
1
Court Order
Judge Mark L. Wolf: ENDORSED ORDER entered granting 231 Motion to Seal (Bono, Christine) (Entered: 04/23/2018)
Entry #233 • 2018-04-23
1
Court Order
MOTION for Order to Begin Trial on August 6, 2018 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 04/23/2018)
Entry #234 • 2018-04-23
1
Court Order
MOTION for Order to Begin Trial on August 6, 2018 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 04/23/2018)
Entry #234 • 2018-04-23
2
MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/04/2018)
Entry #236 • 2018-05-04
1
Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 05/04/2018)
Entry #237 • 2018-05-04
1
Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 05/04/2018)
Entry #237 • 2018-05-04
2
Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 05/04/2018)
Entry #237 • 2018-05-04
2
MEMORANDUM in Support re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 05/04/2018)
Entry #238 • 2018-05-04
1
MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/04/2018)
Entry #239 • 2018-05-04
1
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
1
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MEMORANDUM in Support re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Martin, Andrea) (Entered: 05/04/2018)
Entry #240 • 2018-05-04
2
MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A)(Casey, Alison) (Additional attachment(s) added on 4/20/2022: (1) Exhibit A added in replace of placeholder # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F) (Currie, Haley). (Entered: 05/04/2018)
Entry #241 • 2018-05-04
1
MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A)(Casey, Alison) (Additional attachment(s) added on 4/20/2022: (1) Exhibit A added in replace of placeholder # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F) (Currie, Haley). (Entered: 05/04/2018)
Entry #241 • 2018-05-04
2
MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/04/2018)
Entry #242 • 2018-05-04
1
Assented to MOTION to Seal Exhibits A-F to Janssen's Motion to Exclude the Testimony of Rebecca Betensky, Ph.D. by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/04/2018)
Entry #243 • 2018-05-04
1
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
1
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
MEMORANDUM in Support re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9)(Martin, Andrea) (Entered: 05/04/2018)
Entry #244 • 2018-05-04
2
Motion for Summary Judgment (Rule 56)
Pending / Under Review
MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/04/2018)
Entry #245 • 2018-05-04
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
MEMORANDUM in Support re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/04/2018)
Entry #246 • 2018-05-04
1
Motion for Summary Judgment (Rule 56)
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-29 and 32-54 (Filed Under Seal), # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 55, # 5 Exhibit 56)(Casey, Alison) (Entered: 05/04/2018)
Entry #247 • 2018-05-04
1
Motion for Summary Judgment (Rule 56)
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-29 and 32-54 (Filed Under Seal), # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 55, # 5 Exhibit 56)(Casey, Alison) (Entered: 05/04/2018)
Entry #247 • 2018-05-04
2
Motion for Summary Judgment (Rule 56)
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-29 and 32-54 (Filed Under Seal), # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 55, # 5 Exhibit 56)(Casey, Alison) (Entered: 05/04/2018)
Entry #247 • 2018-05-04
2
Motion for Summary Judgment (Rule 56)
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-29 and 32-54 (Filed Under Seal), # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 55, # 5 Exhibit 56)(Casey, Alison) (Entered: 05/04/2018)
Entry #247 • 2018-05-04
2
Motion for Summary Judgment (Rule 56)
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-29 and 32-54 (Filed Under Seal), # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 55, # 5 Exhibit 56)(Casey, Alison) (Entered: 05/04/2018)
Entry #247 • 2018-05-04
2
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Filed Under Seal) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-29 and 32-54 (Filed Under Seal), # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 55, # 5 Exhibit 56)(Casey, Alison) (Entered: 05/04/2018)
Entry #247 • 2018-05-04
2
Assented to MOTION to Seal re: Dkt 236, 239, 242 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/04/2018)
Entry #248 • 2018-05-04
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Assented to MOTION to Seal Memorandum of Law in Support of Janssen's Motion for Summary Judgment on the Issue of Non-Infringing Alternatives, Statement of Material Facts L.R. 56.1, and Exhibits 1-29 and 32-54 to the Statement of Material Facts by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/04/2018)
Entry #249 • 2018-05-04
1
Court Order
Opposition re 234 MOTION for Order to Begin Trial on August 6, 2018 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 05/07/2018)
Entry #255 • 2018-05-07
1
NOTICE of Withdrawal of Appearance by John C. Adkisson for John C. Adkisson, Robert Oakes, John Kilyk, Jr., and Bruce M. Gagala (Adkisson, John) (Entered: 05/07/2018)
Entry #256 • 2018-05-07
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Barbara L. Mullin Filing fee: $ 100, receipt number 0101-7131442 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit of Barbara L. Mullin)(Casey, Alison) (Entered: 05/09/2018)
Entry #257 • 2018-05-09
1
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Barbara L. Mullin Filing fee: $ 100, receipt number 0101-7131442 by Janssen Biotech, Inc.. (Attachments: # 1 Affidavit of Barbara L. Mullin)(Casey, Alison) (Entered: 05/09/2018)
Entry #257 • 2018-05-09
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 257 Motion for Leave to Appear Pro Hac Vice Added Barbara L. Mullin. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 05/09/2018)
Entry #258 • 2018-05-09
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
Opposition re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/10/2018)
Entry #259 • 2018-05-10
1
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
1
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Pending / Under Review
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 13, # 7 Exhibit 14, # 8 Exhibit 15, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 31, # 12 Exhibit 3-6, 10-12, 16 and 19-30 (Filed Under Seal))(Casey, Alison) (Entered: 05/10/2018)
Entry #260 • 2018-05-10
2
Motion for Summary Judgment (Infringement)
Pending / Under Review
Assented to MOTION to Seal Janssens Memorandum of Law in Opposition to Motion for Summary Judgment for Non-Infringement Based on Ensnarement (Dkt. No. 259), Counter Statement of Material Facts L.R. 56.1 and Accompanying Exhibits (Dkt. No. 260) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/10/2018)
Entry #261 • 2018-05-10
1
Court Order
Judge Mark L. Wolf: ELECTRONIC ORDER entered ALLOWED granting 243 Motion to Seal; granting 248 Motion to Seal; granting 249 Motion to Seal; granting 261 Motion to Seal. (Franklin, Yvonne) (Entered: 05/15/2018)
Entry #263 • 2018-05-15
1
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Extension of Time to 5/21/18 to File Motion in Limine re Discovery Corresp. by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/17/2018)
Entry #264 • 2018-05-17
1
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
1
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MOTION in Limine Nos. 4-14 by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Casey, Alison) (Entered: 05/18/2018)
Entry #265 • 2018-05-18
2
MEMORANDUM in Support re 265 MOTION in Limine Nos. 4-14 Motions in Limine Nos. 4-7 Regarding Infringement filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/18/2018)
Entry #266 • 2018-05-18
1
MEMORANDUM in Support re 265 MOTION in Limine Nos. 4-14 Motions in Limine Nos. 8-10 Regarding Economic Damages filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/18/2018)
Entry #267 • 2018-05-18
1
MEMORANDUM in Support re 265 MOTION in Limine Nos. 4-14 Motions in Limine Nos. 11-12 Regarding Non-Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/18/2018)
Entry #268 • 2018-05-18
1
MEMORANDUM in Support re 265 MOTION in Limine Nos. 4-14 Motion in Limine No. 13 to Preclude Evidence or Argument that Janssen is Employing a Double Standard for Infringement and Validity filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/18/2018)
Entry #269 • 2018-05-18
1
MEMORANDUM in Support re 265 MOTION in Limine Nos. 4-14 Motion in Limine No. 14 to Bifurcate Trial filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/18/2018)
Entry #270 • 2018-05-18
1
Assented to MOTION to Seal Exhibits 1-3, 8-14 and 17-20 to Janssen's Motion in Limine Nos. 4-14 (Dkt. No. 265) and Janssen's Motions in Limine Nos. 11-14 (Dkt. Nos. 268, 269 and 270) by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/18/2018)
Entry #271 • 2018-05-18
1
MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/18/2018)
Entry #272 • 2018-05-18
1
MEMORANDUM in Support re 272 MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #273 • 2018-05-18
1
MEMORANDUM in Support re 272 MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #273 • 2018-05-18
2
MEMORANDUM in Support re 272 MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #273 • 2018-05-18
2
MEMORANDUM in Support re 272 MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #273 • 2018-05-18
2
MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/18/2018)
Entry #274 • 2018-05-18
1
MEMORANDUM in Support re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Martin, Andrea) (Entered: 05/18/2018)
Entry #275 • 2018-05-18
1
MEMORANDUM in Support re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Martin, Andrea) (Entered: 05/18/2018)
Entry #275 • 2018-05-18
2
MEMORANDUM in Support re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Martin, Andrea) (Entered: 05/18/2018)
Entry #275 • 2018-05-18
2
MEMORANDUM in Support re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Martin, Andrea) (Entered: 05/18/2018)
Entry #275 • 2018-05-18
2
MEMORANDUM in Support re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Martin, Andrea) (Entered: 05/18/2018)
Entry #275 • 2018-05-18
2
MEMORANDUM in Support re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Martin, Andrea) (Entered: 05/18/2018)
Entry #275 • 2018-05-18
2
MOTION in Limine to Preclude Evidence and Argument re: Speculation by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/18/2018)
Entry #276 • 2018-05-18
1
MEMORANDUM in Support re 276 MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #277 • 2018-05-18
1
MEMORANDUM in Support re 276 MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #277 • 2018-05-18
2
MEMORANDUM in Support re 276 MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #277 • 2018-05-18
2
MEMORANDUM in Support re 276 MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #277 • 2018-05-18
2
MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/18/2018)
Entry #278 • 2018-05-18
1
MEMORANDUM in Support re 278 MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #279 • 2018-05-18
1
MEMORANDUM in Support re 278 MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #279 • 2018-05-18
2
MEMORANDUM in Support re 278 MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #279 • 2018-05-18
2
MEMORANDUM in Support re 278 MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 05/18/2018)
Entry #279 • 2018-05-18
2
MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/18/2018)
Entry #280 • 2018-05-18
1
MEMORANDUM in Support re 280 MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 05/18/2018)
Entry #281 • 2018-05-18
1
MEMORANDUM in Support re 280 MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 05/18/2018)
Entry #281 • 2018-05-18
2
MEMORANDUM in Support re 280 MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 05/18/2018)
Entry #281 • 2018-05-18
2
MEMORANDUM in Support re 280 MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 05/18/2018)
Entry #281 • 2018-05-18
2
MEMORANDUM in Support re 280 MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 05/18/2018)
Entry #281 • 2018-05-18
2
Assented to MOTION to Seal re: Memos and Exhibits re: Motions in Limine (Dkt 272-280) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/18/2018)
Entry #282 • 2018-05-18
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered ALLOWING 264 Motion for Extension of Time to May 21, 2018; ALLOWING 271 Motion to Seal; ALLOWING 282 Motion to Seal. (Franklin, Yvonne) (Entered: 05/21/2018)
Entry #283 • 2018-05-21
1
MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/21/2018)
Entry #284 • 2018-05-21
1
MEMORANDUM in Support re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1)(Martin, Andrea) (Entered: 05/21/2018)
Entry #285 • 2018-05-21
1
MEMORANDUM in Support re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1)(Martin, Andrea) (Entered: 05/21/2018)
Entry #285 • 2018-05-21
2
Assented to MOTION to Seal re: Dkt 284 Motion in Limine Memorandum by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/21/2018)
Entry #286 • 2018-05-21
1
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to File Excess Pages by 2 pages, re: Opposition to Dkt 245 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/25/2018)
Entry #294 • 2018-05-25
1
Opposition re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #295 • 2018-05-25
1
Opposition re 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #295 • 2018-05-25
2
Assented to MOTION to Seal the Expert Report of Sean Nicholson, Ph.D. by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/25/2018)
Entry #296 • 2018-05-25
1
Opposition re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 05/25/2018)
Entry #297 • 2018-05-25
1
Counter Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-4 (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #298 • 2018-05-25
1
Counter Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-4 (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #298 • 2018-05-25
2
Assented to MOTION to Seal Dkt. Nos. 297 and 298, Janssen's Opposition to Defendants' Motion for Partial Summary Judgment on the Issue of Non-Infringing Alternatives, Counter Statement of Material Facts and Exhibits 1-4 by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/25/2018)
Entry #299 • 2018-05-25
1
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
1
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Opposition re 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A (Filed Under Seal), # 2 Exhibit B (Previously Filed Under Seal), # 3 Exhibit C (Previously Filed Under Seal), # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F (Filed Under Seal), # 7 Exhibit G (Filed Under Seal), # 8 Exhibit H (Filed Under Seal), # 9 Exhibit I (Filed Under Seal), # 10 Exhibit J (Filed Under Seal), # 11 Exhibit K (Filed Under Seal), # 12 Exhibit L (Filed Under Seal), # 13 Exhibit M (Filed Under Seal), # 14 Exhibit N (Filed Under Seal), # 15 Exhibit O (Filed Under Seal), # 16 Exhibit P (Filed Under Seal), # 17 Exhibit Q (Filed Under Seal))(Casey, Alison) (Entered: 05/25/2018)
Entry #300 • 2018-05-25
2
Assented to MOTION to Seal Dkt. No. 300, Janssen's Opposition to Defendants' Motion to Exclude Certain Opinions of Michael Butler and Richard Lit Regarding Damages and Infringement and Accompanying Exhibits by Janssen Biotech, Inc..(Casey, Alison) (Entered: 05/25/2018)
Entry #301 • 2018-05-25
1
Opposition re 241 MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Martin, Andrea) (Entered: 05/25/2018)
Entry #302 • 2018-05-25
1
Opposition re 241 MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Martin, Andrea) (Entered: 05/25/2018)
Entry #302 • 2018-05-25
2
Opposition re 241 MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Martin, Andrea) (Entered: 05/25/2018)
Entry #302 • 2018-05-25
2
Opposition re 241 MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Martin, Andrea) (Entered: 05/25/2018)
Entry #302 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
1
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Opposition re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26)(Martin, Andrea) (Entered: 05/25/2018)
Entry #303 • 2018-05-25
2
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Counter Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives [Filed Under Seal] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 05/25/2018)
Entry #304 • 2018-05-25
1
Assented to MOTION to Seal re: Dkt 302, 303 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/25/2018)
Entry #305 • 2018-05-25
1
Motion for Summary Judgment (Infringement)
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
1
Motion for Summary Judgment (Infringement)
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
2
Motion for Summary Judgment (Infringement)
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
2
Motion for Summary Judgment (Infringement)
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
2
Motion for Summary Judgment (Infringement)
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
2
Motion for Summary Judgment (Infringement)
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
2
Motion for Summary Judgment (Infringement)
Pending / Under Review
REPLY to Response to 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35)(Martin, Andrea) (Entered: 05/29/2018)
Entry #306 • 2018-05-29
2
Motion for Summary Judgment (Infringement)
Pending / Under Review
Counter Statement of Material Facts L.R. 56.1 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] Response to Counterstatement of Facts [Dkt 260] filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 05/29/2018)
Entry #307 • 2018-05-29
1
Assented to MOTION to Seal re Reply and SOF for Ensnarement MSJ by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 05/29/2018)
Entry #308 • 2018-05-29
1
Procedural / Extension Motion
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 286 Motion to Seal; granting 294 Motion for Leave to File Excess Pages ; If counsel has not already done so, counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document.; granting 296 Motion to Seal; granting 299 Motion to Seal; granting 301 Motion to Seal; granting 305 Motion to Seal. (Bono, Christine)
Entry #638 • 2018-05-29
1
No Actions
SEALED UNREDACTED DOCUMENT: RE. 306 by Celltrion Health Care. # 1 Exhibit 30, # 2 Exhibit 31, # 3 Exhibit 32, # 4 Exhibit 33, # 5 Exhibit 34, # 6 Exhibit 35) (Franklin, Yvonne). (Entered: 05/30/2018)
Entry #314 • 2018-05-30
1
Motion for Summary Judgment (Infringement)
Notice of Supplemental Authorities re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] Janssen's Notice of Supplemental Authority (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 06/01/2018)
Entry #316 • 2018-06-01
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
Notice of Supplemental Authorities re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] Janssen's Notice of Supplemental Authority (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 06/01/2018)
Entry #316 • 2018-06-01
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to File Excess Pages by Janssen Biotech, Inc..(Casey, Alison) (Entered: 06/04/2018)
Entry #317 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 4 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #318 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 4 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #318 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 4 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #318 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 4 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #318 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 5 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #319 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 5 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #319 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 5 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #319 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 5 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #319 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 5 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #319 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 6 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #320 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 6 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #320 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 6 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #320 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 6 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Martin, Andrea) (Entered: 06/04/2018)
Entry #320 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 7 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #321 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 7 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #321 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 7 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #321 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 7 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #321 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 7 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Martin, Andrea) (Entered: 06/04/2018)
Entry #321 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 9 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #322 • 2018-06-04
2
REPLY to Response to 241 MOTION to Exclude the Testimony of Rebecca Betensky, Ph.D. filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 06/04/2018)
Entry #323 • 2018-06-04
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
REPLY to Response to 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 06/04/2018)
Entry #324 • 2018-06-04
1
Motion for Summary Judgment (Rule 56)
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Janssen's Reply to Defendants' Statement of Counter-Facts on the Issue of Non-Infringing Alternatives) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-6 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #325 • 2018-06-04
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Statement of Material Facts L.R. 56.1 re 245 MOTION for Summary Judgment on the Issue of Non-Infringing Alternatives (Janssen's Reply to Defendants' Statement of Counter-Facts on the Issue of Non-Infringing Alternatives) filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-6 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #325 • 2018-06-04
2
RESPONSE to Motion re 280 MOTION in Limine to Preclude Evidence and Argument re: Safe Harbor filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 06/04/2018)
Entry #326 • 2018-06-04
1
RESPONSE to Motion re 272 MOTION in Limine to Preclude Evidence and Argument re: Hypothetical Negotiation filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 06/04/2018)
Entry #327 • 2018-06-04
1
Opposition re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 06/04/2018)
Entry #328 • 2018-06-04
1
AFFIDAVIT of A. Robert Quirk in Opposition re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 11, # 4 Exhibit 2-6 and 8-10 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #329 • 2018-06-04
1
AFFIDAVIT of A. Robert Quirk in Opposition re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 11, # 4 Exhibit 2-6 and 8-10 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #329 • 2018-06-04
2
AFFIDAVIT of A. Robert Quirk in Opposition re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 11, # 4 Exhibit 2-6 and 8-10 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #329 • 2018-06-04
2
AFFIDAVIT of A. Robert Quirk in Opposition re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 11, # 4 Exhibit 2-6 and 8-10 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #329 • 2018-06-04
2
AFFIDAVIT of A. Robert Quirk in Opposition re 274 MOTION in Limine to Preclude Evidence and Argument re: Singapore Privilege Instruction filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 11, # 4 Exhibit 2-6 and 8-10 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #329 • 2018-06-04
2
Opposition re 278 MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation, 276 MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-11 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #330 • 2018-06-04
1
Opposition re 278 MOTION in Limine to Preclude Evidence and Argument re: Contract Interpretation, 276 MOTION in Limine to Preclude Evidence and Argument re: Speculation filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-11 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #330 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 12 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #331 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 12 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #331 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 12 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #331 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
1
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
Joint Proposed Jury Instructions by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1 (Janssen's Proposed Preliminary Jury Instructions), # 2 Exhibit 2 (Janssen's Proposed Final Jury Instructions - Liability), # 3 Exhibit 3 (Janssen's Proposed Final Jury Instructions - Damages), # 4 Exhibit 4 (Statement of Janssen's Position on Disputed Jury Instructions), # 5 Exhibit 5 (Defendants' Proposed Preliminary Jury Instructions), # 6 Exhibit 6 (Defendants' Proposed Post-Trial Jury Instructions), # 7 Exhibit 7 (Defendants' Positions on and Objections to Janssen's Proposed Jury Instructions))(Casey, Alison) (Entered: 06/04/2018)
Entry #332 • 2018-06-04
2
REPLY to Response to 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1)(Martin, Andrea) (Entered: 06/04/2018)
Entry #333 • 2018-06-04
1
REPLY to Response to 242 MOTION in Limine To Exclude Opinions of Michael Butler and Richard Lit filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1)(Martin, Andrea) (Entered: 06/04/2018)
Entry #333 • 2018-06-04
2
Opposition re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Casey, Alison) (Entered: 06/04/2018)
Entry #334 • 2018-06-04
1
AFFIDAVIT of Hui Li in Opposition re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 12, # 3 Exhibit 1-3 and 5-11 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #335 • 2018-06-04
1
AFFIDAVIT of Hui Li in Opposition re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 12, # 3 Exhibit 1-3 and 5-11 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #335 • 2018-06-04
2
AFFIDAVIT of Hui Li in Opposition re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 12, # 3 Exhibit 1-3 and 5-11 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #335 • 2018-06-04
2
AFFIDAVIT of Hui Li in Opposition re 284 MOTION in Limine to Preclude Evidence and Argument re pre-suit BPCIA communications filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 12, # 3 Exhibit 1-3 and 5-11 (Filed Under Seal))(Casey, Alison) (Entered: 06/04/2018)
Entry #335 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 11 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 06/04/2018)
Entry #336 • 2018-06-04
1
Assented to MOTION to Seal Janssen's June 4 Filings by Janssen Biotech, Inc..(Casey, Alison) (Entered: 06/04/2018)
Entry #337 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 8 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Martin, Andrea) (Entered: 06/04/2018)
Entry #338 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 13 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1)(Martin, Andrea) (Entered: 06/04/2018)
Entry #339 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 13 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1)(Martin, Andrea) (Entered: 06/04/2018)
Entry #339 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 14 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #340 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 14 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #340 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 14 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #340 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
1
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
Opposition re 265 MOTION in Limine Nos. 4-14 Opposition to Motion in Limine 10 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33)(Martin, Andrea) (Entered: 06/04/2018)
Entry #341 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
1
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 239 MOTION in Limine To Exclude Opinions of Dr. Nicholson re FRE 702 filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Appendix A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Martin, Andrea) (Entered: 06/04/2018)
Entry #342 • 2018-06-04
2
REPLY to Response to 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Martin, Andrea) (Entered: 06/04/2018)
Entry #343 • 2018-06-04
1
Counter Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives Response to Counterstatement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #344 • 2018-06-04
1
Counter Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives Response to Counterstatement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #344 • 2018-06-04
2
Counter Statement of Material Facts L.R. 56.1 re 236 MOTION for Partial Summary Judgment Re: Available and Acceptable Non Infringing Alternatives Response to Counterstatement of Facts filed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/04/2018)
Entry #344 • 2018-06-04
2
Assented to MOTION to Seal Re Dkt 318-322, 331, 333, 336, 338-343 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 06/04/2018)
Entry #345 • 2018-06-04
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
Judge Mark L. Wolf: "It is hereby ORDERED that a hearing on defendants' motion for summary judgment on the issue of ensnarement shall commence onJune 12, 2018, at 10:00 a.m., and continue on June 13, 2018, ifnecessary." ORDER entered. (Bono, Christine) (Entered: 06/05/2018)
Entry #346 • 2018-06-05
1
Motion for Summary Judgment (Infringement)
ELECTRONIC NOTICE Setting Hearing on Motion 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] : Motion Hearing set for 6/12/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Entry #764 • 2018-06-05
1
No Actions
Response by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 316 Notice of Supplemental Authorities, re: Ensnarement Summary Judgment. (Martin, Andrea) (Page 1 only of Main Document 364 replaced to reflect correct security level of document on 6/11/2018) (Bono, Christine). (Entered: 06/11/2018)
Entry #364 • 2018-06-11
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 6/12/2018 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. Exhibit 1 entered (Docket Entry No. 229); Exhibit 2 entered (Docket Entry No. 230); Exhibit A entered (Defendants' MSJ on Ensnarement); and Exhibit B entered (Janssen's Opposition to Defendants' MSJ of Non-Infringement Based on Ensnarement). Hearing continued to 6/13/2018 at 10:00 a.m. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Casey, Harris, Cohen, Hurst, McConnell, Krishnan, Sanford, Martin) (Bono, Christine) (Entered: 06/13/2018)
Entry #365 • 2018-06-12
1
Motion for Summary Judgment (Infringement)
Pending / Under Review
Electronic Clerk's Notes for proceedings held before Judge Mark L. Wolf: Motion Hearing held on 6/13/2018 re 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd. Exhibit C entered (Janssen's Opposition to Defendants' MSJ of Non-Infringement Based on Ensnarement - Supplemental Slides); and Exhibit D entered (Defendants' MSJ on Ensnarement - Rebuttal Presentation). Parties shall confer and report again concerning possible resolution by 6/20/2018. (Court Reporter: Kelly Mortellite at mortellite@gmail.com.)(Attorneys present: Diskant, Fischer, Casey, Quirk, Cohen, Harris, Hurst, McConnell, Krishnan, Sanford, Martin, Kelly) (Bono, Christine) (Entered: 06/13/2018)
Entry #366 • 2018-06-13
1
Motion for Summary Judgment (Infringement)
ELECTRONIC NOTICE Setting Hearing on Motion 226 MOTION for Summary Judgment Non-Infringement Based on Ensnarement [Leave to file granted 4/4/18] : Motion Hearing continued to 6/13/2018 10:00 AM in Courtroom 10 before Judge Mark L. Wolf. (Bono, Christine)
Entry #768 • 2018-06-13
1
No Actions
Court Order
Judge Mark L. Wolf: "As stated in court on June 13, 2018, it is hereby ORDEREDthat the parties shall, by June 20, 2018, confer and report concerning the status of this case." ORDER entered. (Bono, Christine) (Entered: 06/14/2018)
Entry #367 • 2018-06-14
1
BRIEF by Janssen Biotech, Inc. Janssen's Supplemental Submission Regarding Novelty and Non-Obviousness. (Casey, Alison) (Entered: 06/14/2018)
Entry #368 • 2018-06-14
1
Transcript of Motion Hearing held on June 12, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 7/6/2018. Redacted Transcript Deadline set for 7/16/2018. Release of Transcript Restriction set for 9/13/2018. (Scalfani, Deborah) (Entered: 06/15/2018)
Entry #369 • 2018-06-15
1
Transcript of Motion Hearing held on June 13, 2018, before Judge Mark L. Wolf. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Kelly Mortellite at mortellite@gmail.com Redaction Request due 7/6/2018. Redacted Transcript Deadline set for 7/16/2018. Release of Transcript Restriction set for 9/13/2018. (Scalfani, Deborah) (Entered: 06/15/2018)
Entry #370 • 2018-06-15
1
NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/caseinfo/transcripts.htm (Scalfani, Deborah) (Entered: 06/15/2018)
Entry #371 • 2018-06-15
1
Response by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 368 Brief re Novelty and Non-Obviousness. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/18/2018)
Entry #372 • 2018-06-18
1
Response by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 368 Brief re Novelty and Non-Obviousness. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/18/2018)
Entry #372 • 2018-06-18
2
Response by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. to 368 Brief re Novelty and Non-Obviousness. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Martin, Andrea) (Entered: 06/18/2018)
Entry #372 • 2018-06-18
2
Letter/request (non-motion) from Gregory Diskant regarding WesternGeco LLC v. Ion Geophysical Corp. (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 06/22/2018)
Entry #375 • 2018-06-22
1
Letter/request (non-motion) from Gregory Diskant regarding WesternGeco LLC v. Ion Geophysical Corp. (Attachments: # 1 Exhibit A)(Casey, Alison) (Entered: 06/22/2018)
Entry #375 • 2018-06-22
2
Letter/request (non-motion) from Both Parties re: Scheduling. (Martin, Andrea) (Entered: 06/28/2018)
Entry #380 • 2018-06-28
1
Motion for Summary Judgment (Rule 56)
Denied
Judge Mark L. Wolf: "[I]t is hereby ORDERED that: 1. If the pending motion for summary judgment on ensnarement is denied, a telephone conference will be held to discuss plaintiff's intention to seek leave to amend its damages claims and scheduling issues. 2. Unless otherwise ordered, if the motion for summary judgment on ensnarement is denied, hearings on pretrial motions will begin on August 6, 2018, and trial will commence on August 27, 2018. 3. The parties shall continue to confer and, by 12:00 noon on July 6, 2018, report whether they have agreed to a resolution of this case." ORDER entered. (Bono, Christine) (Entered: 06/28/2018)
Entry #381 • 2018-06-28
1
Letter/request (non-motion) from Gregory L. Diskant regarding anticipated motion to reopen damages case.. (Diskant, Gregory) (Entered: 06/29/2018)
Entry #382 • 2018-06-29
1
MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco by Janssen Biotech, Inc..(Casey, Alison) (Entered: 07/13/2018)
Entry #383 • 2018-07-13
1
MEMORANDUM in Support re 383 MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-5 (Filed Under Seal), # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 8)(Casey, Alison) (Entered: 07/13/2018)
Entry #384 • 2018-07-13
1
MEMORANDUM in Support re 383 MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-5 (Filed Under Seal), # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 8)(Casey, Alison) (Entered: 07/13/2018)
Entry #384 • 2018-07-13
2
MEMORANDUM in Support re 383 MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-5 (Filed Under Seal), # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 8)(Casey, Alison) (Entered: 07/13/2018)
Entry #384 • 2018-07-13
2
MEMORANDUM in Support re 383 MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-5 (Filed Under Seal), # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 8)(Casey, Alison) (Entered: 07/13/2018)
Entry #384 • 2018-07-13
2
MEMORANDUM in Support re 383 MOTION for Discovery Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit 1-5 (Filed Under Seal), # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 8)(Casey, Alison) (Entered: 07/13/2018)
Entry #384 • 2018-07-13
2
Assented to MOTION to Seal Exhibits 1-5 Accompanying Janssen's Motion to Reopen Damages Discovery and Adjourn the Damages Trial in Light of the Recent Decision in WesternGeco by Janssen Biotech, Inc..(Casey, Alison) (Entered: 07/13/2018)
Entry #385 • 2018-07-13
1
Procedural / Extension Motion
Pending / Under Review
MOTION for Extension of Time to 8/1/18 to File Response/Reply as to 384 Memorandum in Support of Motion, Plaintiff assented to 7/31/18 only by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 07/19/2018)
Entry #387 • 2018-07-19
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Nikhil R. Krishnan Filing fee: $ 100, receipt number 0101-7246106 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit of Nikhil R. Krishnan)(Martin, Andrea) (Attachment 1 replaced on 7/26/2018) (Franklin, Yvonne). Modified on 7/26/2018 to correct document. (Franklin, Yvonne). (Entered: 07/25/2018)
Entry #388 • 2018-07-25
1
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Nikhil R. Krishnan Filing fee: $ 100, receipt number 0101-7246106 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit of Nikhil R. Krishnan)(Martin, Andrea) (Attachment 1 replaced on 7/26/2018) (Franklin, Yvonne). Modified on 7/26/2018 to correct document. (Franklin, Yvonne). (Entered: 07/25/2018)
Entry #388 • 2018-07-25
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 388 Motion for Leave to Appear Pro Hac Vice Added Nikhil R. Krishnan. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 07/26/2018)
Entry #389 • 2018-07-26
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered ALLOWING 387 MOTION for Extension of Time to 8/1/18 to File Response/Reply as to 384 Memorandum in Support of Motion, Plaintiff assented to 7/31/18 only Responses due by 8/1/2018. (Franklin, Yvonne) (Entered: 07/26/2018)
Entry #390 • 2018-07-26
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Leslie M. Schmidt, Samuel Blake and Sharre Lotfollahi Filing fee: $ 300, receipt number 0101-7249545 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit of Leslie M. Schmidt, # 2 Affidavit of Samuel Blake, # 3 Affidavit of Sharre Lotfollahi)(Martin, Andrea) (Entered: 07/27/2018)
Entry #391 • 2018-07-27
1
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Leslie M. Schmidt, Samuel Blake and Sharre Lotfollahi Filing fee: $ 300, receipt number 0101-7249545 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit of Leslie M. Schmidt, # 2 Affidavit of Samuel Blake, # 3 Affidavit of Sharre Lotfollahi)(Martin, Andrea) (Entered: 07/27/2018)
Entry #391 • 2018-07-27
2
Procedural / Extension Motion
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Leslie M. Schmidt, Samuel Blake and Sharre Lotfollahi Filing fee: $ 300, receipt number 0101-7249545 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit of Leslie M. Schmidt, # 2 Affidavit of Samuel Blake, # 3 Affidavit of Sharre Lotfollahi)(Martin, Andrea) (Entered: 07/27/2018)
Entry #391 • 2018-07-27
2
Procedural / Extension Motion
Pending / Under Review
Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Leslie M. Schmidt, Samuel Blake and Sharre Lotfollahi Filing fee: $ 300, receipt number 0101-7249545 by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. (Attachments: # 1 Affidavit of Leslie M. Schmidt, # 2 Affidavit of Samuel Blake, # 3 Affidavit of Sharre Lotfollahi)(Martin, Andrea) (Entered: 07/27/2018)
Entry #391 • 2018-07-27
2
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: ELECTRONIC ORDER entered granting 391 Motion for Leave to Appear Pro Hac Vice Added Leslie M. Schmidt, Samuel Blake, Sharre Lotfollahi. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Franklin, Yvonne) (Entered: 07/27/2018)
Entry #392 • 2018-07-27
1
Motion for Summary Judgment (Infringement)
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is ALLOWED. 2. Judgment shall enter for the defendants." MEMORANDUM AND ORDER entered granting 226 Motion for Summary Judgment (Attachments: # 1 Exhibit 1, # 2 Exhibit 2) (Bono, Christine) (Entered: 07/30/2018)
Entry #393 • 2018-07-30
1
Motion for Summary Judgment (Infringement)
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is ALLOWED. 2. Judgment shall enter for the defendants." MEMORANDUM AND ORDER entered granting 226 Motion for Summary Judgment (Attachments: # 1 Exhibit 1, # 2 Exhibit 2) (Bono, Christine) (Entered: 07/30/2018)
Entry #393 • 2018-07-30
2
Motion for Summary Judgment (Infringement)
Pending / Under Review
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion for Summary Judgment of Non- Infringement Based on Ensnarement (Docket No. 226) is ALLOWED. 2. Judgment shall enter for the defendants." MEMORANDUM AND ORDER entered granting 226 Motion for Summary Judgment (Attachments: # 1 Exhibit 1, # 2 Exhibit 2) (Bono, Christine) (Entered: 07/30/2018)
Entry #393 • 2018-07-30
2
Court Order
Judge Mark L. Wolf: ORDER entered. JUDGMENT. (Bono, Christine) (Entered: 07/31/2018)
Entry #394 • 2018-07-31
1
Procedural / Extension Motion
Pending / Under Review
MOTION to Amend 394 Judgment Under FRCP 59(e) and/or 60(a) and to Dismiss Without Prejudice Defendants' Invalidity Counterclaim - Unopposed by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc..(Martin, Andrea) (Entered: 08/22/2018)
Entry #395 • 2018-08-22
1
Procedural / Extension Motion
Pending / Under Review
Judge Mark L. Wolf: "...[I]t is hereby ORDERED that: 1. Defendants' Motion to Amend the Judgment (Docket No. 395) is ALLOWED. An Amended Judgment shall enter for defendants on: (a) plaintiff's Counts 1, 2, 3, 4, and 5 and counterclaim Counts 1 and 2, claiming infringement of the '083 patent; and (b) defendants' first counterclaim, seeking a declaration that defendants have not infringed the '083 patent. 2. Defendants' second counterclaim, seeking a declaration that the '083 patent is invalid and/or unenforceable, is DISMISSED without prejudice." ORDER entered granting 395 Motion to Amend (Bono, Christine) (Entered: 08/23/2018)
Entry #396 • 2018-08-23
1
Court Order
Judge Mark L. Wolf: ORDER entered. AMENDED JUDGMENT. (Bono, Christine) (Entered: 08/23/2018)
Entry #397 • 2018-08-23
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
NOTICE OF APPEAL as to 397 Judgment, 393 Order on Motion for Summary Judgment, by Janssen Biotech, Inc. Filing fee: $ 505, receipt number 0101-7289422 Fee Status: Not Exempt. NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov MUST be completed and submitted to the Court of Appeals. Counsel shall register for a First Circuit CM/ECF Appellate Filer Account at http://pacer.psc.uscourts.gov/cmecf. Counsel shall also review the First Circuit requirements for electronic filing by visiting the CM/ECF Information section at http://www.ca1.uscourts.gov/cmecf. US District Court Clerk to deliver official record to Court of Appeals by 9/12/2018. (Repicky, Heather) (Entered: 08/23/2018)
Entry #398 • 2018-08-23
1
Motion for Summary Judgment (Rule 56)
Pending / Under Review
NOTICE OF APPEAL to the Federal Circuit as to 397 Judgment, 393 Order on Motion for Summary Judgment,(Filing fee: $ 505, receipt number 0101-7289422 Fee Status: Not Exempt. ) by Janssen Biotech, Inc. US District Court Clerk to deliver official record to Court of Appeals by 9/13/2018. (Paine, Matthew) (Entered: 08/24/2018)
Entry #399 • 2018-08-24
1
Notice of correction to docket made by Court staff. Correction: Docket Entry 398 Notice of Appeal to the Federal Circuit corrected because: The Notice of Appeal to the Federal Circuit Was Filed Under The Wrong Event By Counsel Repicky. The Notice of Appeal Was Re-Filed Under the Correct Event as ECF No. 399 and the Appeal to the First Circuit Court of Appeals Terminated. (Paine, Matthew) (Entered: 08/24/2018)
Entry #400 • 2018-08-24
1
Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re 399 Notice of Appeal to the Federal Circuit by Janssen Biotech, Inc.. (Paine, Matthew) (Entered: 08/27/2018)
Entry #401 • 2018-08-27
1
USCA Case Number 18-2321 for 399 Notice of Appeal to the Federal Circuit, filed by Janssen Biotech, Inc.. (Paine, Matthew) (Entered: 08/31/2018)
Entry #402 • 2018-08-31
1
Court Order
NOTICE OF CROSS APPEAL as to 397 Judgment by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc.. ( Filing fee: $ 505, receipt number 0101-7299772 (Fee Status: Filing Fee paid)) NOTICE TO COUNSEL: A Transcript Report/Order Form, which can be downloaded from the First Circuit Court of Appeals web site at http://www.ca1.uscourts.gov MUST be completed and submitted to the Court of Appeals. Counsel shall register for a First Circuit CM/ECF Appellate Filer Account at http://pacer.psc.uscourts.gov/cmecf. Counsel shall also review the First Circuit requirements for electronic filing by visiting the CM/ECF Information section at http://www.ca1.uscourts.gov/efiling.htm. US District Court Clerk to deliver official record to Court of Appeals by 9/20/2018. (Martin, Andrea) (Entered: 08/31/2018)
Entry #403 • 2018-08-31
1
Court Order
CROSS NOTICE OF APPEAL to the Federal Circuit as to 397 Judgment, 62 Memorandum & ORDER by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. US District Court Clerk to deliver official record to Court of Appeals by 9/20/2018.( Filing fee: $ 505, receipt number 0101-7299772 (Fee Status: Filing Fee paid) (Paine, Matthew) (Entered: 08/31/2018)
Entry #404 • 2018-08-31
1
Notice of correction to docket made by Court staff. Correction: Docket Entry 403 Cross Notice of Appeal to the Federal Circuit Corrected Because: The Cross Notice of Appeal to the Federal Circuit Was Filed Under The Wrong Event By Counsel Martin. The Cross Notice of Appeal Was Re-Filed Under the Correct Event as ECF No. 404 and the Appeal to the First Circuit Court of Appeals Terminated. (Paine, Matthew) (Entered: 08/31/2018)
Entry #405 • 2018-08-31
1
Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re 404 Cross Notice of Appeal to the Federal Circuit. (Paine, Matthew) (Entered: 09/04/2018)
Entry #406 • 2018-09-04
1
USCA Case Number 18-2350 for 404 Cross Notice of Appeal to the Federal Circuit, filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd.. (Paine, Matthew) (Entered: 09/10/2018)
Entry #407 • 2018-09-10
1
NOTICE of Withdrawal of Appearance by Irena Royzman (Royzman, Irena) (Entered: 06/19/2019)
Entry #408 • 2019-06-19
1
Notice of Withdrawal of Counsel - Daniel A. Friedman by Janssen Biotech, Inc..(Friedman, Daniel) Modified on 7/24/2019 to edit description of pleading(Montes, Mariliz). (Entered: 07/22/2019)
Entry #409 • 2019-07-22
1
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
1
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Procedural / Extension Motion
Pending / Under Review
Joint MOTION to Unseal Document and Leave to File Redacted Public Versions by Janssen Biotech, Inc.. (Attachments: # 1 Dkt. No. 15-9, # 2 Dkt. No. 15-10, # 3 Dkt. No. 15-11, # 4 Dkt. No. 306-2, # 5 Dkt. No. 306-4, # 6 Dkt. No. 306-5, # 7 Dkt. No. 340-2 (15-cv-10698), # 8 Dkt. No. 340-3 (15-cv-10698), # 9 Dkt. No. 343-1 (15-cv-10698), # 10 Dkt. No. 15-2, # 11 Dkt. No. 15-5, # 12 Dkt. No. 227, # 13 Dkt. No. 260-12, # 14 Dkt. No. 306-1)(Casey, Alison) (Entered: 10/17/2019)
Entry #410 • 2019-10-17
2
Court Order
Proposed Document(s) submitted by Janssen Biotech, Inc.. Document received: Proposed Order Unsealing Portions of the Record [D.I. 410]. (Casey, Alison) (Entered: 10/17/2019)
Entry #411 • 2019-10-17
1
Court Order
Judge Mark L. Wolf: ORDER entered granting 410 Joint Motion to Unseal Portions of the Record. (Loret, Magdalena) (Entered: 11/25/2019)
Entry #412 • 2019-11-25
1
Court Order
Judge Mark L. Wolf: ORDER entered re 411 Order Unsealing Portions of the Record.(Loret, Magdalena) (Entered: 11/25/2019)
Entry #413 • 2019-11-25
1
NOTICE of Withdrawal of Appearance of Elizabeth A. Cutri by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Hospira, Inc. Notice of Withdrawal of Attorney Elizabeth A. Cutri (Martin, Andrea) Modified on 1/27/2020 to edit description of filing (Montes, Mariliz). (Entered: 01/24/2020)
Entry #414 • 2020-01-24
1
USCA Judgment for the Federal Circuit as to 404 Notice of Appeal to the Federal Circuit, filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd., 399 Notice of Appeal to the Federal Circuit, filed by Janssen Biotech, Inc.. AFFIRMED... (Paine, Matthew) (Entered: 03/05/2020)
Entry #415 • 2020-03-05
1
MANDATE of USCA as to 404 Notice of Appeal to the Federal Circuit, filed by Celltrion, Inc., Hospira, Inc., Celltrion Healthcare Co., Ltd., 399 Notice of Appeal to the Federal Circuit, filed by Janssen Biotech, Inc.. Appeal 404, 399 Terminated (Paine, Matthew) (Entered: 04/13/2020)
Entry #416 • 2020-04-13
1